Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3006257	s-achr-ab	— (—)	2268	2396	100.00%	Distribution not available
3006257	s-achr-ab	nmol/l (nmol/l)	518	582	5.33%
3006257	s-achr-ab	nmol/l____ (nmol/l)	9	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of ocular muscles, binocular movement, accommodation and refraction

637

1221

5.27

308.61

1.1

2.64

7.92

nmol/l

2.22

116

232

Diseases of the myoneural junction and muscle

419

251

17.98

307.65

1.3

1.1

13.49

0.11

nmol/l

8.57

199

Other symptoms and signs involving the nervous and musculoskeletal systems

681

905

7.72

307.65

1.1

3.08

7.92

nmol/l

1.41

117

172

Visual disturbances

901

1047

8.87

307.65

1.1

3.89

7.82

nmol/l

1.10

186

189

Visual disturbances and blindness

912

1130

8.29

307.65

1.1

3.87

7.67

nmol/l

1.17

187

210

Strabismus

478

623

7.89

307.65

1.1

2.40

9.93

nmol/l

1.75

121

Symptoms and signs involving the nervous and musculoskeletal systems

938

1279

7.52

307.65

1.1

3.10

7.94

nmol/l

1.96

162

241

Diplopia

599

239

27.71

307.65

1.1

4.62

15.80

nmol/l

0.89

125

Myasthenia gravis

276

114.12

307.65

1.4

1.1

12.96

0.10

nmol/l

—

182

Ptosis of eyelid

378

224

18.20

307.65

1.1

6.01

15.42

nmol/l

0.64

Other disorders of eyelid

527

948

5.34

255.00

1.1

6.13

7.40

nmol/l

0.21

120

163

Dysphagia

364

552

6.75

228.27

1.1

6.77

8.06

nmol/l

0.16

122

Malaise and fatigue

553

910

4.85

225.52

1.1

2.02

9.78

nmol/l

2.90

176

Disorders of eyelid, lacrimal system and orbit

811

1656

3.63

222.83

1.1

6.33

5.63

nmol/l

0.15

158

278

Paralytic strabismus

198

139

15.20

220.96

1.1

3.17

7.00

nmol/l

0.91

Neurological diseases

594

581

5.17

213.94

1.1

1.0

9.53

0.54

nmol/l

2.28

116

Subjective visual disturbances

336

533

6.45

201.73

1.1

2.19

10.76

nmol/l

1.46

Abnormalities of gait and mobility

225

226

10.35

199.26

1.1

0.70

17.90

nmol/l

1.74

Other strabismus

319

496

6.57

194.39

1.1

1.72

10.65

nmol/l

1.62

Headache

589

1188

3.87

180.59

1.1

1.68

8.64

nmol/l

2.95

214

Other soft tissue disorders, not elsewhere classified

742

1332

3.19

155.33

1.1

3.77

7.49

nmol/l

1.19

113

263

Diseases of the eye and adnexa

531

645

4.15

151.25

1.1

2.85

4.50

nmol/l

0.58

100

Myalgia

278

534

5.30

136.50

1.1

0.96

9.55

nmol/l

2.00

110

Neurological diseases, wide definition

218

103

10.73

133.49

1.1

5.54

0.48

nmol/l

1.14

General symptoms and signs

737

1269

2.93

128.50

1.1

3.06

8.46

nmol/l

2.18

121

234

Disturbances of skin sensation

320

735

4.43

126.81

1.1

1.19

9.26

nmol/l

2.22

133

Migraine

434

917

3.72

126.54

1.1

2.90

6.93

nmol/l

0.98

168

Medical observation and evaluation for suspected diseases and conditions

461

600

3.96

124.96

1.1

3.96

9.44

nmol/l

1.10

137

Other headache syndromes

364

937

3.91

122.77

1.1

4.90

7.49

nmol/l

0.41

177

Symptoms and signs involving cognition, perception, emotional state and behaviour

724

1821

2.67

117.80

1.1

3.75

6.48

nmol/l

0.90

114

351

Symptoms and signs involving speech and voice

346

896

3.92

116.67

1.1

9.80

7.02

nmol/l

0.38

165

Pain in limb

606

1316

2.95

115.77

1.1

3.81

7.55

nmol/l

1.15

261

Pain in joint

432

727

3.68

114.66

1.1

2.80

9.85

nmol/l

2.01

157

Episodal and paroxysmal disorders

716

1336

2.73

111.51

1.1

4.96

7.00

nmol/l

0.47

129

251

Speech disturbances, not elsewhere classified

155

203

7.90

111.50

1.1

11.35

8.26

nmol/l

0.24

Examination and observation for other reasons

400

594

3.83

108.41

1.1

2.39

9.51

nmol/l

1.77

136

Disorders of thyroid, IBD co-morbidities

136

11.91

107.76

1.0

1.1

8.16

0.54

nmol/l

—

Abnormalities of breathing

630

1289

2.81

107.50

1.1

4.39

5.98

nmol/l

0.37

103

243

Systemic atrophies primarily affecting the central nervous system

109

11.94

105.38

1.1

0.09

4.93

nmol/l

1.54

Abnormal involuntary movements

169

259

6.68

105.18

1.1

4.49

18.30

nmol/l

1.10

Parkinson's disease, excluding more controls

117

11.04

105.01

1.1

5.26

0.53

nmol/l

0.64

Extrapyramidal and movement disorders

359

1025

3.55

104.87

1.1

7.11

7.53

nmol/l

0.04

207

Polyneuropathies and other disorders of the peripheral nervous system

242

519

4.75

104.65

1.1

2.14

11.59

nmol/l

2.07

106

Concussion

276

475

4.53

104.44

1.1

4.08

0.68

nmol/l

1.28

Intracranial trauma

304

482

4.28

102.11

1.1

4.74

0.66

nmol/l

1.54

Other and unspecified polyneuropathies, also in other diseases

220

450

4.99

100.75

1.1

2.28

11.53

nmol/l

1.77

Other neurological diseases

544

1542

2.76

97.68

1.1

2.29

7.63

nmol/l

2.89

310

Parkinson's disease, strict definition, excluding more controls

109

10.87

97.55

1.0

1.1

5.91

0.57

nmol/l

0.64

Heterophoria

133

171

8.03

97.17

1.1

0.72

6.88

nmol/l

1.30

Dizziness and giddiness

551

1605

2.69

94.50

1.1

3.88

6.73

nmol/l

0.82

314

Low back pain

535

1305

2.78

94.42

1.1

2.49

7.47

nmol/l

2.19

263

Dorsalgia

648

1324

2.61

93.94

1.1

3.90

7.45

nmol/l

1.12

110

264

General examination and investigation of persons without complaint and reported diagnosis

400

598

3.49

92.96

1.1

4.41

9.51

nmol/l

0.93

136

Symptoms and signs involving the skin and subcutaneous tissue

548

2004

2.60

92.07

1.1

2.72

6.52

nmol/l

2.02

100

365

Other specific joint derangements/joint disorders

540

1250

2.71

88.53

1.1

2.15

6.36

nmol/l

1.62

238

Other dorsopathies, not elsewhere classified

644

1329

2.53

87.55

1.1

4.31

7.45

nmol/l

0.91

106

264

Pain in throat and chest

560

1266

2.63

85.74

1.1

5.74

5.98

nmol/l

0.03

243

Anxiety disorders, excluding more controls

568

1429

2.55

83.78

1.1

2.60

7.16

nmol/l

1.79

285

Fibromyalgia

132

199

6.81

83.58

1.1

0.10

16.29

nmol/l

1.03

Autoimmune diseases excluding thyroid diseases

665

1500

2.41

83.36

1.2

1.1

9.15

2.03

nmol/l

2.95

198

195

Nerve, nerve root and plexus disorders

713

1869

2.30

82.98

1.1

3.53

6.66

nmol/l

1.26

127

343

Sixth [abducent] nerve palsy

12.79

82.90

1.1

3.19

3.86

nmol/l

0.11

Other disorders of lacrimal gland

296

870

3.44

82.75

1.1

6.18

7.67

nmol/l

0.18

153

Other intervertebral disc disorders

538

1232

2.62

81.70

1.1

2.79

7.30

nmol/l

1.67

247

Intermittent heterotropia

100

112

9.23

81.55

1.2

1.1

0.52

3.60

nmol/l

0.50

Dyspnoea

624

1913

2.37

81.01

1.1

4.31

6.46

nmol/l

0.71

109

347

Autoimmune diseases excluding thyroid diseases, strict definition

637

1441

2.42

80.09

1.2

1.1

8.85

2.00

nmol/l

2.68

191

186

Pain, not elsewhere classified

230

583

3.99

79.97

1.1

2.50

9.86

nmol/l

1.46

117

Lower back pain or/and sciatica

713

2004

2.22

77.19

1.1

3.82

6.23

nmol/l

0.88

122

372

ILD medications: prednisolone, methylprednisolone, prednisone

706

1754

2.25

76.21

1.1

6.83

3.73

nmol/l

1.03

168

267

Anxiety disorders

612

1817

2.32

75.29

1.1

2.51

5.95

nmol/l

1.39

347

Sciatica+with lumbago

364

1113

2.92

75.22

1.1

4.50

7.62

nmol/l

0.66

222

Disorders of lacrimal system

321

1033

3.08

74.92

1.1

6.59

6.83

nmol/l

0.03

180

Oral corticosteroids

690

1816

2.24

74.85

1.1

6.25

4.06

nmol/l

0.67

160

283

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

610

1782

2.32

74.72

1.1

4.02

6.21

nmol/l

0.62

105

327

Spondylopathies

496

1133

2.60

74.37

1.1

4.25

7.87

nmol/l

0.96

232

Migraine with aura

210

526

4.04

74.23

1.1

1.04

7.55

nmol/l

1.16

Neurotic, stress-related and somatoform disorders

605

1808

2.32

74.11

1.1

2.51

6.02

nmol/l

1.42

343

Mood disorders, excluding more controls

592

1503

2.33

70.22

1.1

2.33

7.02

nmol/l

2.42

101

295

Other antidepressants

625

1388

2.31

70.02

1.1

3.62

7.43

nmol/l

1.35

105

273

Other special examinations and investigations of persons without complaint or reported diagnosis

364

600

3.09

70.02

1.1

4.23

9.44

nmol/l

1.01

137

Inflammatory bowel disease treatment related agents

718

1869

2.14

68.97

1.1

7.04

4.06

nmol/l

0.96

178

287

Autoimmune diseases

660

1509

2.23

68.19

1.1

8.05

2.03

nmol/l

2.32

171

195

Symptoms and signs involving the circulatory and respiratory systems

598

1291

2.33

68.08

1.1

5.52

5.98

nmol/l

0.07

109

243

Somatoform disorder

172

403

4.34

66.72

1.1

1.44

10.92

nmol/l

1.49

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

192

196

4.94

66.63

1.1

3.89

10.45

nmol/l

0.43

Used for control exclusion in common control thyroid runs

613

1370

2.27

65.65

1.1

8.44

2.13

nmol/l

2.10

159

171

Depression

622

1917

2.18

65.61

1.1

3.25

6.41

nmol/l

1.16

103

360

Dorsopathies

598

1336

2.28

64.81

1.1

4.25

7.42

nmol/l

0.90

265

Condition for Implicit Sepsis (Organ dysfunction codes)

559

1725

2.26

64.60

1.1

3.84

6.21

nmol/l

0.71

325

Vertical strabismus

10.49

64.17

1.2

1.1

3.50

1.68

nmol/l

0.36

Soft tissue disorders

592

1340

2.27

64.13

1.1

3.35

7.47

nmol/l

1.39

106

264

Spondylosis

354

1017

2.74

63.27

1.1

5.73

8.34

nmol/l

0.49

211

Migraine without aura

173

424

4.13

63.12

1.1

0.69

7.94

nmol/l

1.03

Third [oculomotor] nerve palsy

15.04

62.83

1.1

4.22

1.19

nmol/l

—

ILD medications

687

1776

2.09

62.04

1.1

7.64

3.73

nmol/l

1.32

169

268

Implicit Sepsis, including avohilmo

537

1719

2.24

61.69

1.1

3.96

6.22

nmol/l

0.65

325

Persons encountering health services for specific procedures and health care

669

1903

2.08

61.15

1.1

8.29

5.04

nmol/l

0.40

372

Care involving use of rehabilitation procedures

439

1665

2.39

61.10

1.1

3.34

5.32

nmol/l

0.59

324

Other/unspecified dorsalgia

255

823

3.08

59.80

1.1

2.13

8.02

nmol/l

1.82

176

First line medication for Crohn's disease

665

1727

2.08

59.09

1.1

6.35

4.78

nmol/l

0.40

159

275

Mood disorders

635

1966

2.07

58.56

1.1

3.28

6.30

nmol/l

1.12

105

370

Abnormalities of heart beat

252

801

3.07

58.55

1.1

3.16

8.25

nmol/l

0.87

149

Sleep apnoea

589

1745

2.14

58.45

1.1

4.78

6.49

nmol/l

0.43

112

307

Other symptoms and signs involving cognitive functions and awareness

314

1021

2.75

58.22

1.1

4.50

8.28

nmol/l

0.77

209

Recurrent or chronic depression

263

583

3.15

58.17

1.1

1.59

8.12

nmol/l

1.48

118

Mood [affective] disorders

632

1969

2.06

57.63

1.1

3.28

6.30

nmol/l

1.12

105

370

Other extrapyramidal and movement disorders in other diseases

213

646

3.34

56.92

1.1

4.20

9.39

nmol/l

0.60

125

Tramadol

489

1293

2.28

56.24

1.1

3.36

7.41

nmol/l

1.34

240

Symptoms and signs involving the digestive system and abdomen

557

1274

2.20

55.75

1.1

6.58

6.92

nmol/l

0.05

243

Lumbar disc prolapse

392

1189

2.45

55.72

1.1

2.42

7.46

nmol/l

2.03

238

Sleep apnoea, including avohilmo

612

1794

2.07

55.54

1.1

4.77

6.25

nmol/l

0.37

111

321

Other and unspecified myopathies

101

176

5.87

55.46

1.1

4.45

0.11

nmol/l

0.79

STROKE

372

993

2.54

55.22

1.1

3.67

7.55

nmol/l

1.06

202

ILD medications: azathioprine

145

346

4.26

54.99

1.2

1.1

13.09

11.14

nmol/l

0.11

Fourth [trochlear] nerve palsy

12.44

54.57

1.2

1.1

1.17

5.32

nmol/l

—

Asthma (only as main-diagnosis), excluding more controls

431

994

2.41

54.40

1.1

6.57

6.08

nmol/l

0.06

170

Asthma

467

1042

2.32

53.35

1.1

5.65

7.24

nmol/l

0.24

177

Azathioprine

145

355

4.15

53.16

1.2

1.1

13.09

11.02

nmol/l

0.12

Asthma, excluding more controls

453

994

2.35

53.07

1.1

5.84

6.08

nmol/l

0.03

170

Pain (limb, back, neck, head abdominally)

376

733

2.58

52.95

1.1

7.75

9.79

nmol/l

0.26

158

Asthma (mode)

461

1049

2.32

52.81

1.1

5.64

7.24

nmol/l

0.24

177

Other degenerative diseases of the nervous system

139

222

4.59

52.53

1.1

2.74

0.95

nmol/l

0.39

Asthma (only as main-diagnosis)

436

1042

2.35

52.39

1.1

6.57

7.24

nmol/l

0.08

177

Depression or dysthymia

376

819

2.52

51.89

1.1

2.99

8.38

nmol/l

1.51

166

Persons encountering health services for examination and investigation

326

600

2.74

51.22

1.1

4.84

9.44

nmol/l

0.83

137

Other general symptoms and signs

8.14

51.13

1.1

1.2

0.13

10.74

nmol/l

1.28

Cerebrovascular diseases (FINNGEN)

225

499

3.19

50.85

1.1

4.01

10.02

nmol/l

0.81

Codeine

538

1389

2.10

49.31

1.1

4.20

7.45

nmol/l

1.00

101

257

Anxiety (asthma-related co-morbidities)

390

1286

2.32

49.22

1.1

3.11

7.29

nmol/l

0.97

231

Postprocedural disorders of nervous system

173

5.57

48.79

1.1

0.13

5.56

nmol/l

0.95

All anxiety disorders

398

1360

2.28

48.76

1.1

2.95

6.43

nmol/l

0.84

256

Opioids

560

1405

2.07

48.55

1.1

4.07

7.38

nmol/l

0.99

105

260

Spinal stenosis

299

854

2.60

47.69

1.1

4.12

9.60

nmol/l

1.32

178

Sleep disorders (combined)

613

1633

1.97

46.79

1.1

5.00

6.53

nmol/l

0.38

123

283

Other and unspecified visual disturbances

100

202

5.03

46.68

1.2

1.1

6.39

11.60

nmol/l

0.48

Voice disturbances

210

716

2.96

46.10

1.1

8.68

8.00

nmol/l

0.06

132

Migraine with aura and triptan purchases

143

386

3.75

45.78

1.1

0.57

5.46

nmol/l

1.34

Anaemias

137

205

4.31

45.75

1.1

0.56

7.64

nmol/l

1.31

Implicit Sepsis

464

1637

2.10

45.71

1.1

3.92

6.70

nmol/l

0.78

303

Systemic connective tissue disorders

249

935

2.69

45.55

1.1

2.32

8.23

nmol/l

1.60

178

Fever of other and unknown origin

306

1092

2.44

44.66

1.1

3.16

9.34

nmol/l

2.20

207

Blepharochalasis

190

624

3.07

44.54

1.1

6.88

8.26

nmol/l

0.13

104

Other reaction to severe stress, and adjustment disorders

248

940

2.66

44.42

1.1

3.36

7.32

nmol/l

0.66

183

Other systemic involvement of connective tissue (FG)

190

613

3.07

44.28

1.1

2.90

9.32

nmol/l

1.10

117

Other diseases of intestines

610

1775

1.92

44.27

1.1

7.67

5.28

nmol/l

0.32

110

319

Persons encountering health services for other counselling and medical advice, not elsewhere classified

630

1761

1.91

44.23

1.1

4.10

6.14

nmol/l

0.62

121

314

Any mental disorder

593

1524

1.96

44.04

1.1

2.81

7.15

nmol/l

1.84

100

299

Dystonia

133

6.04

43.96

1.1

12.19

1.54

nmol/l

0.58

Hypothyroidism (congenital or acquired)

150

209

4.04

43.90

1.0

1.1

1.90

7.64

nmol/l

0.90

Cervicobrachial syndrome

162

490

3.34

43.57

1.1

1.74

11.06

nmol/l

1.79

103

Infections, IBD-co-morbidities

7.49

42.87

1.1

0.46

0.68

nmol/l

—

Asthma, unspecified (mode), excluding more controls

318

954

2.40

42.78

1.1

8.10

6.11

nmol/l

0.27

166

Migraine without aura and triptan purchases

142

402

3.57

42.39

1.1

0.82

2.75

nmol/l

0.72

Hypothyroidism and >3 levothyroxin purchases

146

209

3.94

41.41

1.1

2.00

7.64

nmol/l

0.87

Hypothyroidism, levothyroxine purchases

146

209

3.94

41.41

1.1

2.00

7.64

nmol/l

0.87

Asthma, unspecified (mode)

323

1000

2.34

41.41

1.1

8.10

7.32

nmol/l

0.09

172

Other disorders of binocular movement

9.87

40.96

1.2

1.1

1.18

0.11

nmol/l

—

Finngen Rheumatological endpoints

539

1579

1.94

40.76

1.1

4.60

6.07

nmol/l

0.35

290

Syncope and collapse

250

816

2.57

40.48

1.1

5.30

9.38

nmol/l

0.68

160

Metabolic disorders

540

1692

1.92

40.01

1.1

4.29

5.89

nmol/l

0.47

317

Other disorders of eye and adnexa

135

387

3.54

39.63

1.1

0.87

11.95

nmol/l

1.73

Abdominal and pelvic pain

504

1274

1.99

39.58

1.1

4.16

6.92

nmol/l

0.69

243

Disorders of refraction and accommodation

193

681

2.85

39.51

1.1

2.79

8.49

nmol/l

1.11

129

Other anxiety disorders

291

1058

2.35

39.15

1.1

1.06

7.03

nmol/l

2.46

198

Shoulder lesions

408

1165

2.11

38.87

1.1

3.02

7.78

nmol/l

1.83

237

Other joint disorders

485

1269

2.00

38.86

1.1

3.03

6.28

nmol/l

0.86

241

GASTRO-related operations

430

1030

2.10

38.80

1.1

11.09

5.75

nmol/l

0.53

201

Any gastric operation

430

1030

2.10

38.80

1.1

11.09

5.75

nmol/l

0.53

201

Asthma, including avohilmo

656

2018

1.80

38.66

1.1

5.73

5.37

nmol/l

0.07

121

363

Persons encountering health services in other circumstances, wide

626

1764

1.83

38.54

1.1

5.10

6.19

nmol/l

0.27

120

315

Cerebrovascular diseases

417

1419

2.05

38.14

1.1

4.59

7.27

nmol/l

0.76

274

Other sleep disorders

202

4.56

37.97

1.1

1.86

9.44

nmol/l

1.97

Cerebral cysts

135

5.54

37.77

1.1

0.25

5.42

nmol/l

—

Asthma (diagnoses ohter than nonallergic)

506

2176

1.88

37.75

1.1

5.33

5.82

nmol/l

0.10

391

Codeine or tramadol medication

622

1871

1.81

37.61

1.1

3.84

6.50

nmol/l

1.00

112

344

Symptoms and signs involving the urinary system

439

1684

1.97

37.04

1.1

3.80

6.91

nmol/l

1.10

327

Diseases of the musculoskeletal system and connective tissue

269

536

2.53

36.61

1.1

6.16

9.34

nmol/l

0.33

100

Hypothyroidism, strict autoimmune

382

1204

2.09

36.52

1.1

5.53

2.36

nmol/l

0.61

156

Non-invasive ventilation

157

438

3.12

36.52

1.1

1.19

10.49

nmol/l

1.45

Use of levodopa decarboxylase inhibitor

116

320

3.68

36.11

1.1

1.83

14.50

nmol/l

1.90

282

1242

2.27

35.88

1.1

6.96

7.06

nmol/l

0.01

236

Asthma-related infections

356

1691

2.06

35.59

1.1

6.53

6.04

nmol/l

0.08

312

Asthma, hospital admission 2, infections

356

1691

2.06

35.59

1.1

6.53

6.04

nmol/l

0.08

312

Selective serotonin reuptake inhibitors

508

1390

1.91

35.58

1.1

3.44

7.43

nmol/l

1.45

273

Cervicalgia

143

457

3.16

35.25

1.1

1.11

10.81

nmol/l

1.82

Other systemic involvement of connective tissue

192

724

2.68

35.00

1.1

2.90

8.78

nmol/l

1.10

137

Nonorganic sleeping disorders, excluding more controls

139

440

3.19

34.80

1.1

3.98

11.51

nmol/l

0.80

Depression medications

149

215

3.50

34.75

1.1

1.08

7.64

nmol/l

1.16

Psychiatric diseases

498

1317

1.90

34.25

1.1

5.09

6.33

nmol/l

0.24

259

Migraine, single triptan purchase ok & required. ICD-code if available is included

443

1563

1.93

34.16

1.1

2.54

6.33

nmol/l

1.52

285

Triptan medication for migraine, single purchase ok

443

1563

1.93

34.16

1.1

2.54

6.33

nmol/l

1.52

285

Cardiovascular diseases

334

814

2.19

33.83

1.1

3.11

4.57

nmol/l

0.26

150

Obesity related asthma

236

998

2.38

33.77

1.1

3.18

7.89

nmol/l

1.22

184

Temporomandibular joint disorders, including avohilmo

296

1330

2.17

33.69

1.1

3.31

6.38

nmol/l

0.80

252

Parkinson's disease, including avohilmo

121

360

3.40

33.58

1.0

1.1

4.75

13.57

nmol/l

0.93

Personality disorders, excluding more controls

157

545

2.89

33.32

1.1

0.80

8.94

nmol/l

1.85

109

Transient ischemic attack

290

1051

2.21

33.30

1.0

1.1

4.09

7.96

nmol/l

0.93

214

ILD medications: immunosuppressive drugs

359

1626

2.01

33.00

1.2

1.1

10.13

3.82

nmol/l

1.88

113

247

Antihypertensive medication - note that there are other indications

340

831

2.15

32.81

1.1

3.03

4.32

nmol/l

0.23

153

Parkinson's disease

117

346

3.42

32.79

1.1

5.26

14.12

nmol/l

0.83

Disorders of the thyroid gland

519

1872

1.80

32.38

1.1

5.46

6.20

nmol/l

0.14

336

Cardiac arrhythmias

350

1093

2.06

32.16

1.1

2.94

6.24

nmol/l

0.77

206

Asthma, hospital admissions , main diagnosis only

460

2196

1.83

31.73

1.1

6.63

5.51

nmol/l

0.20

387

Rheumatism, unspecified

102

282

3.66

31.69

1.1

4.31

12.60

nmol/l

0.60

Vocal cord dysfunction

195

4.10

31.63

1.2

1.1

15.86

13.82

nmol/l

—

Chronic lower respiratory diseases

647

2007

1.70

31.59

1.1

5.89

5.24

nmol/l

0.12

116

361

COPD differential diagnosis

411

1050

1.97

31.32

1.1

4.15

7.24

nmol/l

0.68

177

ILD differential diagnosis

410

1049

1.97

31.11

1.1

4.15

7.24

nmol/l

0.68

177

Excluding asthma or asthma-COPD overlap

410

1053

1.96

30.79

1.1

4.15

7.91

nmol/l

0.86

181

Other pulmonary diagnosis

410

1053

1.96

30.79

1.1

4.24

7.91

nmol/l

0.84

181

Parkinson's disease, strict definition

109

321

3.44

30.79

1.0

1.1

5.91

14.12

nmol/l

0.70

Factors influencing health status and contact with health services

135

199

3.42

30.54

1.1

4.37

9.35

nmol/l

0.75

Ischaemic Stroke, excluding all haemorrhages

301

1054

2.11

30.43

1.1

4.89

8.15

nmol/l

0.72

211

Pain in thoracic spine

112

338

3.35

30.41

1.1

11.35

12.38

nmol/l

0.05

Generalized anxiety disorder

119

373

3.21

30.29

1.1

1.32

3.53

nmol/l

0.79

Cough

224

901

2.33

30.27

1.1

1.47

7.59

nmol/l

2.01

167

Arthropathies

466

1271

1.86

30.16

1.1

5.03

6.28

nmol/l

0.22

241

Hypothyroidism, other/unspecified

478

1746

1.81

30.05

1.1

4.78

6.26

nmol/l

0.34

315

Benzodiazepine use

550

2153

1.73

30.03

1.1

2.88

6.16

nmol/l

1.58

407

Enthesopathies of lower limb, excluding foot

143

503

2.86

29.84

1.1

1.12

11.15

nmol/l

2.13

104

Diseases of oesophagus, stomach and duodenum

571

1964

1.72

29.83

1.1

6.00

5.28

nmol/l

0.14

369

Small fibre neuropathy

6.41

29.80

1.1

1.92

4.01

nmol/l

—

Rotator cuff syndrome

323

1090

2.05

29.76

1.1

3.11

8.06

nmol/l

1.68

226

Other disorders of urethra and urinary system

393

1440

1.91

29.60

1.1

8.10

6.23

nmol/l

0.27

261

Cardiovascular diseases (excluding rheumatic etc)

345

978

2.03

29.50

1.1

3.47

5.85

nmol/l

0.37

174

Other diseases of the respiratory system

135

464

2.94

29.41

1.1

3.97

11.85

nmol/l

1.18

Other respiratory disorders and diseases

135

464

2.94

29.41

1.1

3.97

11.85

nmol/l

1.18

Disorders of vestibular function (Vertigo)

280

1309

2.09

29.29

1.1

2.68

7.64

nmol/l

1.49

253

Nausea and vomiting

154

555

2.72

29.09

1.1

3.50

8.47

nmol/l

0.72

116

Other and unspecified myoneural disorders

45.81

29.07

1.3

1.2

35.05

—

nmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

196

521

2.51

28.92

1.1

2.15

9.95

nmol/l

1.79

124

Constipation

484

1857

1.77

28.77

1.1

8.37

5.42

nmol/l

0.26

355

Dentofacial anomalies [including malocclusion]

407

1727

1.85

28.70

1.1

3.75

5.82

nmol/l

0.58

314

Implicit viral Sepsis, including avohilmo

192

796

2.42

28.64

1.1

3.64

8.86

nmol/l

0.78

157

Hypothyreosis and Thyroxine purchase for inclusion criteria

493

1841

1.76

28.45

1.1

4.61

6.25

nmol/l

0.41

340

Respiratory insufficiency

139

4.72

28.35

1.1

0.32

26.02

nmol/l

1.25

Acute upper respiratory infections of multiple and unspecified sites

423

1694

1.83

28.30

1.1

3.65

6.05

nmol/l

0.64

313

Gastro-oesophageal reflux disease

381

1727

1.87

28.06

1.1

7.59

5.62

nmol/l

0.36

321

Chronic rhinitis, nasopharyngitis and pharyngitis

206

892

2.32

28.00

1.1

1.97

7.89

nmol/l

1.82

170

Parasetamol

365

941

1.97

27.94

1.1

5.54

5.53

nmol/l

0.00

189

Cervical disc disorders

192

807

2.39

27.93

1.1

2.89

8.80

nmol/l

1.53

166

588

1768

1.69

27.83

1.1

4.57

6.08

nmol/l

0.42

112

318

Cramp and spasm

122

4.95

27.02

1.1

4.91

3.07

nmol/l

—

Acute upper respiratory infections

543

1934

1.69

26.56

1.1

3.12

6.33

nmol/l

1.56

356

Disorders of lipoprotein metabolism and other lipidaemias

429

1452

1.80

26.44

1.1

5.08

6.66

nmol/l

0.37

276

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

294

1439

1.98

26.35

1.1

4.85

6.29

nmol/l

0.27

263

Diseases of inner ear

306

1507

1.95

26.31

1.1

2.71

7.17

nmol/l

1.49

295

Disorders of synovium and tendon

275

1148

2.04

26.25

1.1

2.75

7.63

nmol/l

1.70

226

Disorders of muscles

209

3.82

26.24

1.1

2.79

17.54

nmol/l

1.34

Autoimmune diseases related-to ILD

458

2225

1.72

25.85

1.1

5.32

5.69

nmol/l

0.07

410

Irritable bowel syndrome

175

735

2.40

25.58

1.1

1.86

5.19

nmol/l

1.70

142

Other heart diseases

249

758

2.14

25.56

1.1

3.59

7.12

nmol/l

0.49

138

Pain and other conditions associated with female genital organs and menstrual cycle

140

434

2.72

25.45

1.1

0.64

6.10

nmol/l

2.12

Stroke, excluding SAH

303

1116

1.97

25.33

1.1

5.27

8.24

nmol/l

0.65

220

Autonomic disorders

6.79

25.26

1.1

0.42

1.09

nmol/l

—

Hypothyroidism, drug reimbursement

142

3.96

25.02

1.1

1.0

0.16

9.71

nmol/l

—

Complications of surgical and medical care, not elsewhere classified

524

2109

1.66

24.82

1.1

2.96

6.33

nmol/l

1.23

398

Hard cardiovascular diseases

425

1419

1.78

24.82

1.1

6.12

6.49

nmol/l

0.06

270

Oedema, not elsewhere classified

169

692

2.40

24.67

1.1

3.09

9.92

nmol/l

1.66

138

Other functional intestinal disorders

252

1123

2.05

24.65

1.1

0.47

6.26

nmol/l

5.78

208

Symptoms and signs concerning food and fluid intake

195

3.83

24.64

1.1

0.12

18.70

nmol/l

—

Asthma/COPD (KELA code 203)

501

2006

1.67

24.38

1.1

7.01

5.24

nmol/l

0.33

361

Disorders of conjunctiva

451

2061

1.70

23.95

1.1

6.28

5.01

nmol/l

0.21

358

Hypertensive diseases (excluding secondary)

270

771

2.05

23.93

1.1

3.43

7.30

nmol/l

0.54

135

Bronchitis

567

2107

1.62

23.71

1.1

5.18

5.73

nmol/l

0.11

107

379

COPD/asthma related infections

515

1546

1.67

23.52

1.1

4.11

6.28

nmol/l

0.60

102

277

COPD/asthma/ILD related infections

515

1546

1.67

23.52

1.1

4.11

6.28

nmol/l

0.60

102

277

Brachial plexus disorders

241

3.45

23.37

1.1

1.24

4.46

nmol/l

0.75

Any reimbursement code in KELA

289

727

2.00

23.20

1.1

5.42

1.87

nmol/l

0.98

110

Diseases of the respiratory system

321

840

1.92

23.06

1.1

6.27

7.32

nmol/l

0.13

145

Hyperkinetic disorders, excluding more controls

220

3.46

22.94

1.2

1.1

0.16

5.25

nmol/l

—

Coxibs

137

260

2.78

22.80

1.1

1.0

4.91

8.33

nmol/l

0.52

Other heart diseases, wide

475

1726

1.67

22.53

1.1

3.45

6.00

nmol/l

0.76

300

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

202

954

2.13

22.35

1.0

1.1

4.58

6.89

nmol/l

0.31

181

L04AX Other immunosuppressants

310

1697

1.83

22.29

1.2

1.1

10.63

4.54

nmol/l

1.62

100

278

Cerebral palsy and other paralytic syndromes

269

3.23

22.19

1.1

0.49

6.75

nmol/l

1.89

Stroke, including SAH

310

1198

1.86

22.14

1.1

5.15

7.97

nmol/l

0.64

233

Carpal tunnel syndrome

317

1509

1.83

22.03

1.1

4.55

6.75

nmol/l

0.40

277

Restless leg syndrome

110

398

2.79

21.98

1.1

6.34

12.28

nmol/l

0.38

Second line medication for Crohn's disease

317

1757

1.81

21.85

1.2

1.1

10.53

4.47

nmol/l

1.63

101

285

Triptan medication for migraine, min. 3 purchases

321

1316

1.83

21.83

1.1

2.36

6.32

nmol/l

1.21

231

Blepharospasm

9.35

21.81

1.2

1.1

0.28

0.12

nmol/l

—

Use of pramipexole

139

567

2.47

21.78

1.1

7.11

10.27

nmol/l

0.29

112

Gastrointestinal diseases

286

734

1.96

21.76

1.1

5.42

6.46

nmol/l

0.15

130

Implicit viral Sepsis

127

500

2.56

21.44

1.1

0.34

11.33

nmol/l

2.62

102

Post-traumatic stress disorder

178

3.75

21.40

1.1

0.64

5.75

nmol/l

—

Viral Sepsis

127

501

2.55

21.35

1.1

0.34

11.26

nmol/l

2.64

103

Other arrhythmias

341

1434

1.78

21.26

1.1

1.85

6.53

nmol/l

2.37

256

Other diseases of urinary system

494

1704

1.63

21.13

1.1

5.56

6.03

nmol/l

0.08

305

Deforming dorsopathies

143

599

2.40

21.09

1.1

3.78

9.09

nmol/l

0.81

122

Oxicams

116

231

2.87

20.99

1.2

1.0

8.32

8.87

nmol/l

0.04

Pure hypercholesterolaemia

372

1361

1.74

20.77

1.1

5.10

6.90

nmol/l

0.39

262

Intestinal infectious diseases, including avohilmo, including avohilmo

574

2045

1.57

20.76

1.1

5.90

5.73

nmol/l

0.03

108

365

Non-selective monoamine reuptake inhibitors

189

859

2.12

20.61

1.1

2.83

9.49

nmol/l

1.83

178

Atypical facial pain

126

4.29

20.49

1.2

1.1

0.44

3.52

nmol/l

—

Traumatic subdural haemorrhage

108

4.44

20.44

1.0

1.1

13.27

0.46

nmol/l

0.77

Dermatitis and eczema

563

2140

1.56

20.32

1.1

3.64

6.21

nmol/l

1.13

105

387

Certain infectious and parasitic diseases

481

1477

1.64

20.26

1.1

4.39

6.08

nmol/l

0.41

261

Dermatitis

331

1860

1.75

20.22

1.1

3.81

6.63

nmol/l

1.03

337

Hypermobility syndrome

136

4.12

20.19

1.1

0.13

8.03

nmol/l

0.86

Radiculopathy

334

2.87

20.03

1.1

3.86

12.95

nmol/l

1.02

Endocrine, nutritional and metabolic diseases

379

1105

1.74

19.93

1.1

5.19

5.82

nmol/l

0.09

205

Diseases of the ear and mastoid process

558

1791

1.56

19.66

1.1

3.09

6.79

nmol/l

1.57

104

332

Conjunctivitis

395

1923

1.66

19.36

1.1

6.72

5.35

nmol/l

0.21

329

Other degenerative diseases of the basal ganglia

6.93

19.27

1.0

1.2

—

9.73

nmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

477

2037

1.59

19.07

1.1

5.14

5.83

nmol/l

0.11

377

Dissociative [conversion] disorders

4.98

19.02

1.2

1.1

0.10

4.87

nmol/l

—

Ocular pain

238

3.19

18.99

1.1

0.78

7.48

nmol/l

1.49

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

507

2079

1.57

18.98

1.1

6.04

5.72

nmol/l

0.05

368

Provisional assignment of new diseases of uncertain etiology

281

1559

1.79

18.90

1.1

2.16

7.38

nmol/l

2.87

295

Codes for special purposes

281

1561

1.79

18.81

1.1

2.16

7.38

nmol/l

2.87

295

Other enthesopathies

154

701

2.21

18.77

1.1

2.52

8.99

nmol/l

1.61

148

430

1546

1.63

18.57

1.1

4.95

6.28

nmol/l

0.29

277

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

430

1546

1.63

18.57

1.1

4.95

6.28

nmol/l

0.29

277

Nonorganic sleeping disorders

139

610

2.29

18.55

1.1

3.98

6.50

nmol/l

0.30

116

Thyrotoxicosis, other and/or unspecified

123

512

2.42

18.52

1.0

1.1

7.36

8.00

nmol/l

0.04

100

Other diseases of upper respiratory tract

525

1756

1.56

18.51

1.1

4.93

6.60

nmol/l

0.42

100

314

Polyuria

130

555

2.36

18.49

1.1

3.49

10.38

nmol/l

1.21

115

Hypothyroidism, strict autoimmune, 3 medication purchases required

415

1715

1.63

18.46

1.1

5.43

6.17

nmol/l

0.14

320

Hypertension, essential

389

1320

1.67

18.34

1.1

7.58

6.13

nmol/l

0.20

238

Intestinal infectious diseases

473

2247

1.57

18.28

1.1

6.51

5.40

nmol/l

0.20

407

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

135

583

2.30

18.09

1.1

7.21

8.45

nmol/l

0.08

111

Allergic asthma (mode)

125

517

2.37

17.97

1.1

1.66

10.44

nmol/l

1.31

Exposure to unspecified factor

508

2245

1.54

17.95

1.1

3.02

6.23

nmol/l

1.70

399

Other CVD (FINNGEN)

172

3.26

17.94

1.1

2.21

15.84

nmol/l

0.74

Pain associated with micturition

294

2.89

17.93

1.0

1.1

0.36

15.54

nmol/l

2.11

Enlarged lymph nodes

305

2.84

17.89

1.1

0.29

15.58

nmol/l

2.04

Allergic asthma (mode), excluding more controls

125

519

2.36

17.82

1.1

1.66

9.30

nmol/l

1.12

Other and unspecified dermatitis

275

1559

1.77

17.77

1.1

2.88

6.57

nmol/l

1.55

289

Oxycodone

196

847

1.99

17.64

1.1

3.74

9.92

nmol/l

1.11

157

Certain infectious and parasitic diseases, including avohilmo

345

1008

1.72

17.59

1.1

10.46

4.86

nmol/l

0.57

176

Sequelae of cerebrovascular disease

178

744

2.05

17.53

1.1

4.75

9.04

nmol/l

0.59

154

Use of hypnotics and sedatives

527

1970

1.53

17.49

1.1

4.94

5.71

nmol/l

0.13

377

Astigmatism

128

3.95

17.48

1.0

1.1

4.62

8.17

nmol/l

—

Bell's palsy

277

2.92

17.43

1.1

4.45

13.11

nmol/l

0.77

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

486

2122

1.55

17.40

1.1

4.33

6.18

nmol/l

0.58

383

Exclusions for E4_PCOS_BROAD

112

460

2.45

17.37

1.1

1.21

11.54

nmol/l

1.81

Sleep disorders

455

2004

1.57

17.32

1.1

5.39

5.65

nmol/l

0.04

371

Acute sinusitis

272

1402

1.77

17.30

1.1

2.11

6.26

nmol/l

1.75

261

Complications of procedures, not elsewhere classified

406

2052

1.60

17.24

1.1

2.92

6.37

nmol/l

0.94

387

Hypertensive diseases

390

1345

1.64

17.17

1.1

6.25

6.08

nmol/l

0.02

240

Complications of medical and surgical care

371

2059

1.62

17.12

1.1

3.08

6.55

nmol/l

0.95

376

Benign neoplasm: Cerebral meninges

238

3.06

17.06

1.2

1.1

9.48

14.03

nmol/l

0.20

Endometriosis

177

492

2.10

17.00

1.1

8.04

5.94

nmol/l

0.26

Benign neoplasm of meninges

265

2.94

16.99

1.2

1.1

8.85

15.08

nmol/l

0.33

Hypertension

389

1345

1.64

16.96

1.1

6.25

6.08

nmol/l

0.02

240

Intracranial injury

290

1572

1.72

16.93

1.1

4.94

7.40

nmol/l

0.51

302

Disorders of other endocrine glands

231

1242

1.84

16.87

1.1

1.44

7.43

nmol/l

2.92

230

Benign neoplasms

472

1653

1.56

16.71

1.1

4.50

5.83

nmol/l

0.28

291

Other symptoms and signs involving the digestive system and abdomen

368

2.60

16.70

1.1

0.81

8.78

nmol/l

1.25

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

329

1725

1.66

16.67

1.1

5.79

6.89

nmol/l

0.21

313

Special screening examination for infectious and parasitic diseases

105

301

2.55

16.63

1.1

2.26

13.62

nmol/l

1.24

Continuous positive airway pressure

301

2.64

16.62

1.1

2.58

12.13

nmol/l

0.92

Implicit bacterial Sepsis, including avohilmo

225

1010

1.86

16.60

1.1

5.03

8.10

nmol/l

0.58

190

Polyarthropathies

304

1136

1.72

16.58

1.1

4.47

6.32

nmol/l

0.34

218

Personality disorders

157

758

2.08

16.56

1.1

0.80

5.51

nmol/l

2.73

138

Persons encountering health services in other circumstances

205

1074

1.90

16.54

1.1

6.67

7.06

nmol/l

0.05

198

Disorders of adult personality and behaviour

162

792

2.06

16.52

1.1

1.09

5.80

nmol/l

2.61

143

Missing teeth due to accident, extraction or parodontitis

311

1656

1.68

16.50

1.1

3.26

7.51

nmol/l

2.04

308

Demyelinating diseases of the central nervous system

227

3.08

16.49

1.1

3.79

5.50

nmol/l

0.18

Acetic acid derivatives and related substances

122

256

2.47

16.41

1.1

6.85

8.33

nmol/l

0.11

Faecal incontinence

187

3.30

16.37

1.1

1.25

12.46

nmol/l

—

Neuralgia and neuritis, unspecified

108

4.13

16.35

1.0

1.1

0.14

9.52

nmol/l

—

Other inflammation of eyelid

315

2.72

16.33

1.1

4.88

12.64

nmol/l

0.53

Caries of dentine

120

503

2.31

16.30

1.1

1.49

8.43

nmol/l

1.32

105

Paracetamol or NSAID medication

129

3.14

16.26

1.1

1.27

6.82

nmol/l

1.24

Convergent concomitant strabismus

118

3.95

16.11

1.1

0.12

4.14

nmol/l

—

Cystitis

403

1512

1.59

15.87

1.1

4.66

6.16

nmol/l

0.32

273

Other and unspecified nerve root and plexus disorders, also in other diseases

118

518

2.29

15.82

1.1

2.72

10.04

nmol/l

1.20

Injuries to the head

541

2166

1.48

15.67

1.1

4.27

5.98

nmol/l

0.51

399

Chronic sinusitis

219

1206

1.82

15.61

1.1

2.07

6.80

nmol/l

1.87

222

Other arthrosis

245

916

1.80

15.60

1.1

3.29

7.56

nmol/l

1.05

178

Other diseases of hard tissues of teeth

259

748

1.80

15.58

1.1

9.17

7.91

nmol/l

0.16

152

Other disorders of ear

444

1878

1.53

15.15

1.1

2.82

6.50

nmol/l

1.70

353

Asthma and allergy, excluding more controls

251

2.85

15.12

1.1

1.08

14.86

nmol/l

0.90

Hypotension

393

2.46

15.08

1.1

7.02

13.21

nmol/l

0.59

External causes of morbidity and mortality

315

939

1.69

15.07

1.1

4.96

8.93

nmol/l

0.76

165

Asthma and allergy

252

2.84

15.00

1.1

1.08

17.47

nmol/l

1.10

Panic disorder

341

2.57

14.98

1.1

10.53

4.22

nmol/l

—

Persistent mood disorders

108

468

2.32

14.95

1.1

2.05

11.87

nmol/l

1.84

Other inflammation of eyelid, including avohilmo

209

1153

1.82

14.90

1.1

5.97

5.83

nmol/l

0.01

199

Diarrhoea and gastroenteritis of presumed infectious origin

348

1958

1.59

14.84

1.1

8.17

5.13

nmol/l

0.49

360

Oter anti-inflammatory and antirheumatic agents, non-steroids

100

215

2.57

14.81

1.1

1.0

11.28

9.76

nmol/l

0.12

Spondylolisthesis/Spondylolysis

392

2.44

14.68

1.1

5.23

11.87

nmol/l

0.63

Benign paroxysmal vertigo

159

808

1.98

14.63

1.1

4.26

8.32

nmol/l

0.59

155

Neuromuscular dysfunction of bladder

206

3.04

14.61

1.1

0.55

14.44

nmol/l

—

Spasmodic torticollis

4.44

14.57

1.1

5.93

0.81

nmol/l

—

Other diseases of pleura

213

1028

1.81

14.53

1.1

3.04

8.33

nmol/l

1.66

212

Specific personality disorders

135

649

2.09

14.48

1.1

0.75

3.27

nmol/l

1.71

115

Insomnia

437

2010

1.52

14.46

1.1

5.57

5.65

nmol/l

0.01

369

Functional dyspepsia

149

744

2.01

14.41

1.1

3.16

6.89

nmol/l

0.63

144

Asthma-related pneumonia

182

971

1.88

14.31

1.1

7.17

7.84

nmol/l

0.07

181

Myopia

291

2.67

14.30

1.1

2.31

6.17

nmol/l

0.70

Disorders of orbit

4.15

14.22

1.1

1.33

1.70

nmol/l

—

Asthma, hospital admissions 3, pneumonia

182

974

1.87

14.18

1.1

7.17

7.84

nmol/l

0.07

181

Asthma-related pneumonia or sepsis

182

974

1.87

14.18

1.1

7.17

7.84

nmol/l

0.07

181

Thyrotoxicosis

140

688

2.05

14.17

1.0

1.1

7.07

7.94

nmol/l

0.07

132

Accidents

379

1205

1.58

14.10

1.1

5.11

8.32

nmol/l

0.72

207

Chronic laryngitis and laryngotracheitis

328

2.55

14.09

1.1

0.99

13.36

nmol/l

1.64

Diverticular disease of intestine

326

1258

1.62

14.01

1.1

7.54

6.26

nmol/l

0.22

234

Autoimmune hyperthyroidism

121

3.68

14.00

1.1

0.82

0.10

nmol/l

—

Other nutritional deficiencies

340

1977

1.57

13.98

1.1

1.96

6.33

nmol/l

2.38

353

Other shoulder lesions

207

2.97

13.86

1.0

1.1

2.07

15.60

nmol/l

1.17

Mycoses, including avohilmo

447

2293

1.49

13.73

1.1

6.47

5.33

nmol/l

0.23

405

Urinary track infection

292

876

1.67

13.68

1.1

6.23

6.42

nmol/l

0.02

139

Dental caries

124

558

2.11

13.45

1.1

1.77

7.81

nmol/l

1.20

114

Implicit bacterial Sepsis

196

932

1.81

13.44

1.1

5.31

8.43

nmol/l

0.52

177

Disease of hard tissues of teeth, NOS

246

743

1.74

13.33

1.1

6.47

7.88

nmol/l

0.19

150

Other specified/unspecified systemic involvement of connective tissue

136

3.43

13.17

1.2

1.1

0.39

5.95

nmol/l

0.64

Other CVD

103

463

2.24

13.13

1.1

6.36

12.20

nmol/l

0.62

Trochanteric bursitis

316

2.52

13.11

1.1

2.80

13.25

nmol/l

1.27

Implicit fungal Sepsis, including avohilmo

177

3.09

13.07

1.1

0.24

11.43

nmol/l

—

Covid-19 confirmed case

181

996

1.82

13.04

1.1

2.62

7.88

nmol/l

1.82

197

Haemorrhage from respiratory passages

149

681

1.94

12.85

1.1

4.35

8.46

nmol/l

0.62

131

Other external causes of accidental injury

372

1205

1.55

12.83

1.1

4.84

8.32

nmol/l

0.81

207

Urticaria

160

853

1.88

12.82

1.1

0.58

7.70

nmol/l

2.43

157

Urticaria and erythema

190

1070

1.78

12.74

1.1

1.26

7.06

nmol/l

2.18

194

Certain disorders involving the immune mechanism

108

502

2.17

12.71

1.1

1.85

11.08

nmol/l

1.69

Hyperkinetic disorders

330

2.44

12.67

1.2

1.1

0.15

3.51

nmol/l

—

Influenza and pneumonia

500

2145

1.44

12.65

1.1

4.28

5.74

nmol/l

0.43

109

369

Guillain-Barre syndrome

5.39

12.58

1.1

0.12

2.22

nmol/l

—

Osteopathies and chondropathies

271

1535

1.62

12.55

1.1

3.26

6.93

nmol/l

1.05

286

Paroxysmal tachycardia

107

408

2.19

12.52

1.1

1.77

10.71

nmol/l

1.23

Injuries to the thorax

220

1298

1.70

12.48

1.1

2.92

6.67

nmol/l

1.17

242

Retention of urine

160

688

1.89

12.46

1.1

1.88

10.39

nmol/l

2.49

148

Conjunctivitis (acute, non atopic), including avohilmo

470

1955

1.45

12.45

1.1

6.31

5.92

nmol/l

0.06

344

Chronic apical periodontitis

522

2051

1.43

12.45

1.1

5.63

5.94

nmol/l

0.06

369

Undetermined asthma, excluding more controls

277

2.58

12.40

1.1

3.62

15.33

nmol/l

0.91

Other disorders of fluid, electrolyte and acid-base balance

149

737

1.91

12.38

1.1

7.59

8.29

nmol/l

0.06

146

Ischemic heart diseases

373

1461

1.52

12.36

1.1

5.37

6.74

nmol/l

0.23

278

Bacterial Sepsis

215

1039

1.72

12.28

1.1

5.62

8.06

nmol/l

0.42

194

Undetermined asthma

279

2.56

12.22

1.1

3.62

17.62

nmol/l

1.13

Metatarsalgia

201

2.86

12.14

1.0

1.1

3.95

19.25

nmol/l

—

Excessive, frequent and irregular menstruation

180

521

1.85

12.08

1.1

8.40

5.74

nmol/l

0.24

Arthrosis

307

1062

1.59

12.01

1.1

7.77

6.81

nmol/l

0.13

202

Obesity, other/unspecified

180

1017

1.78

11.99

1.1

2.75

7.61

nmol/l

1.23

189

Diagnoses used for exclusion with ILD

127

642

1.99

11.96

1.1

1.90

10.40

nmol/l

2.00

125

Pneumonia, organism unspecified

431

2029

1.46

11.92

1.1

5.37

5.89

nmol/l

0.10

355

Trigeminal neuralgia

135

3.30

11.91

1.2

1.1

1.02

7.46

nmol/l

—

Fall on same level

531

2005

1.41

11.84

1.1

4.79

6.13

nmol/l

0.36

370

Other disorders of patella

394

2.27

11.83

1.1

1.98

10.37

nmol/l

1.23

Anti-inflammatory and antirheumatic products, non-steroids

116

270

2.17

11.77

1.2

1.1

3.39

8.06

nmol/l

1.12

Exclusions for E4_PCOS_CONSORTIUM

346

1417

1.53

11.76

1.1

9.00

5.06

nmol/l

0.30

239

Deviated nasal septum

156

849

1.84

11.72

1.1

2.25

7.72

nmol/l

1.55

156

Other enthesopathy of foot (+metatarsalgia)

222

2.72

11.69

1.0

1.1

3.95

17.65

nmol/l

—

Injury, poisoning and certain other consequences of external causes

247

742

1.67

11.64

1.1

2.90

7.44

nmol/l

1.70

140

Disturbance of activity and attention

314

2.41

11.63

1.2

1.1

0.15

3.64

nmol/l

—

Diaphragmatic hernia

174

983

1.78

11.61

1.1

6.32

8.58

nmol/l

0.31

185

Disorders of lens

297

1173

1.57

11.52

1.1

9.47

6.85

nmol/l

0.35

210

Hemiplegia

123

3.38

11.51

1.0

1.1

0.09

3.86

nmol/l

—

Emotionally unstable personality disorder

325

2.39

11.45

1.1

1.09

3.74

nmol/l

0.78

Haemorrhoids and perianal venous thrombosis

160

879

1.81

11.43

1.1

16.69

6.84

nmol/l

0.34

171

Gonarthrosis

272

956

1.61

11.41

1.1

6.60

7.28

nmol/l

0.07

185

Osteoporosis with pathological fracture (FG)

149

3.12

11.40

1.1

1.50

18.15

nmol/l

0.73

Spirochaetal infections, other/unspecified

231

2.67

11.39

1.1

1.51

14.28

nmol/l

1.17

Gonarthrosis [arthrosis of knee](FG)

324

1212

1.54

11.32

1.1

6.76

7.04

nmol/l

0.03

227

Benign neoplasm of colon, rectum, anus and anal canal

288

1570

1.55

11.20

1.1

3.84

7.36

nmol/l

1.09

288

Fracture of rib(s), sternum and thoracic spine

148

806

1.84

11.17

1.1

2.51

9.13

nmol/l

1.65

155

Meniscus derangement

237

959

1.64

11.15

1.1

8.38

7.41

nmol/l

0.10

185

Hyperlipidaemia, other/unspecified

174

890

1.76

11.14

1.1

4.37

7.91

nmol/l

0.66

177

Propionic acid derivatives

114

270

2.13

11.12

1.1

2.32

8.06

nmol/l

1.57

Lesion of ulnar nerve

324

2.36

11.06

1.1

3.07

13.95

nmol/l

—

Obesity and other hyperalimentation

312

1937

1.52

11.05

1.1

2.25

6.38

nmol/l

2.03

349

Other metabolic disorders

349

2.31

11.05

1.0

1.1

4.21

12.65

nmol/l

0.79

Allergic conjunctivitis

279

1732

1.55

11.03

1.1

6.57

5.56

nmol/l

0.12

301

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

285

1814

1.54

11.00

1.1

3.94

6.86

nmol/l

0.51

344

Sarcoidosis

338

2.33

10.95

1.1

2.30

7.43

nmol/l

1.17

Pneumonias (Asthma/COPD co-morbidities)

469

2169

1.41

10.93

1.1

5.27

5.58

nmol/l

0.06

384

Superficial injury of head

120

614

1.96

10.92

1.1

2.65

9.93

nmol/l

1.51

116

Atrial fibrillation and flutter

134

447

1.94

10.89

1.1

5.62

9.79

nmol/l

0.33

Emergency coronary revascularization (for ACS)

371

1517

1.48

10.81

1.1

5.56

6.96

nmol/l

0.25

292

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

460

2168

1.41

10.80

1.1

5.49

5.65

nmol/l

0.03

382

Percutaneous Coronary Intervention

345

1402

1.50

10.76

1.1

5.79

6.92

nmol/l

0.17

270

Disorders of lacrimal system and orbit in diseases classified elsewhere

4.64

10.76

1.1

1.13

0.27

nmol/l

—

Obesity

309

1931

1.51

10.71

1.1

2.28

6.39

nmol/l

2.00

348

Coronary revascularization (ANGIO or CABG)

345

1403

1.50

10.66

1.1

5.79

6.92

nmol/l

0.17

270

Ganglion

478

2.08

10.63

1.1

2.06

12.34

nmol/l

1.72

Non-allergic asthma (mode)

396

2.19

10.59

1.1

2.53

12.48

nmol/l

1.22

Speech and linguistic disorders, excluding more controls

130

3.12

10.59

1.1

1.2

4.10

8.72

nmol/l

0.37

Disorders of psychological development

254

2.46

10.54

1.2

1.1

3.32

4.08

nmol/l

0.07

Candidiasis, including avohilmo

156

880

1.78

10.52

1.1

5.90

6.84

nmol/l

0.08

165

Cervicocranial syndrome

229

2.59

10.51

1.1

2.20

14.31

nmol/l

1.04

Convulsions, not elsewhere classified

435

2.12

10.47

1.1

0.33

11.02

nmol/l

2.39

100

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

260

1601

1.56

10.47

1.1

6.91

5.47

nmol/l

0.16

275

Lateral epicondylitis

289

2.40

10.46

1.1

1.74

14.53

nmol/l

—

Other cataract

195

860

1.69

10.44

1.1

3.78

7.54

nmol/l

0.71

155

Endometriosis of pelvic peritoneum

346

2.22

10.43

1.1

1.43

6.22

nmol/l

1.29

All pneumoniae

468

2171

1.40

10.42

1.1

5.22

5.60

nmol/l

0.08

383

Non-allergic asthma (mode), excluding more controls

399

2.17

10.40

1.1

2.53

10.81

nmol/l

0.99

Exposure to other specified factors

379

2256

1.44

10.40

1.1

3.72

5.77

nmol/l

0.60

409

Unspecified urinary incontinence

213

2.65

10.40

1.0

1.1

7.81

16.30

nmol/l

0.41

Coxarthrosis

210

815

1.67

10.40

1.1

7.13

8.19

nmol/l

0.14

162

Diseases of oral cavity, salivary glands and jaws

237

751

1.63

10.26

1.1

8.55

7.96

nmol/l

0.06

154

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

421

2318

1.42

10.22

1.1

8.01

5.19

nmol/l

0.22

431

Diseases of salivary glands

163

940

1.74

10.20

1.1

1.32

7.97

nmol/l

2.49

181

Persons encountering health services for specific procedures, not carried out

210

2.64

10.14

1.2

1.1

5.83

8.04

nmol/l

0.15

Epilepsy

117

610

1.92

10.04

1.1

0.37

8.29

nmol/l

2.02

117

Abnormal findings on diagnostic imaging of central nervous system

129

3.14

10.04

1.0

1.1

8.34

2.58

nmol/l

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

320

2.30

10.01

1.1

4.50

13.26

nmol/l

0.75

Diseases of pulp and periapical tissues and dental caries

282

935

1.55

9.93

1.1

6.54

8.26

nmol/l

0.26

181

Diseases of the skin and subcutaneous tissue

437

1548

1.42

9.92

1.1

7.71

6.01

nmol/l

0.17

295

Menorrhagia

154

475

1.81

9.92

1.1

8.86

6.12

nmol/l

0.25

Other and unspecified injuries of head

173

2.80

9.90

1.0

1.1

0.93

7.35

nmol/l

—

Hypopituitarism

173

2.80

9.90

1.1

1.75

4.34

nmol/l

0.69

Dental pulpitis, including avohilmo

428

1949

1.41

9.79

1.1

1.48

6.41

nmol/l

3.66

347

Bipolar affective disorders

460

2.05

9.78

1.1

0.96

6.84

nmol/l

2.31

Other bacterial diseases, including avohilmo

462

2078

1.39

9.73

1.1

5.81

5.62

nmol/l

0.03

374

Neoplasms

343

1220

1.48

9.73

1.1

2.74

4.23

nmol/l

0.47

211

Irregular menses

239

1143

1.57

9.72

1.1

3.05

5.47

nmol/l

0.41

198

Diseases of pulp and periapical tissues, including avohilmo

459

1699

1.40

9.71

1.1

5.25

6.52

nmol/l

0.28

309

Soft tissue disorders related to use, overuse and pressure

123

662

1.87

9.71

1.1

7.32

9.74

nmol/l

0.25

136

Sicca syndrome [Sjögren]

215

2.58

9.70

1.1

5.08

15.92

nmol/l

0.56

KRA_PSY_EATING, excluding more controls

162

2.83

9.70

1.1

0.08

7.24

nmol/l

—

363

2.19

9.69

1.1

2.02

11.72

nmol/l

1.06

Major coronary heart disease event

363

1498

1.45

9.69

1.1

5.47

6.90

nmol/l

0.25

287

SLE (Finngen)

4.22

9.65

1.1

0.36

0.08

nmol/l

—

Other disorders of bone

106

546

1.95

9.57

1.1

0.52

10.18

nmol/l

2.20

106

Injuries to the neck

119

637

1.88

9.57

1.1

8.34

6.39

nmol/l

0.23

121

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

108

484

1.95

9.56

1.1

0.15

4.08

nmol/l

1.46

Unspecified/other endometriosis

190

2.65

9.45

1.1

10.30

6.88

nmol/l

—

Cerebral aneurysm, nonruptured

213

2.56

9.37

1.1

9.45

17.28

nmol/l

0.36

Other/unspecified enthesopathies of lower limb, excluding foot

151

2.87

9.32

1.2

1.1

2.38

9.34

nmol/l

—

Other bacterial diseases

420

1994

1.40

9.25

1.1

4.95

5.87

nmol/l

0.22

370

Falls/tendency to fall

479

1745

1.38

9.19

1.1

4.79

6.47

nmol/l

0.44

320

Myositis

4.33

9.15

1.0

1.1

0.98

4.72

nmol/l

—

Benign neoplasm: Stomach

247

2.41

9.03

1.1

9.20

16.01

nmol/l

0.32

Other spirochaetal diseases

164

982

1.68

9.01

1.1

4.59

7.92

nmol/l

0.60

182

Other disorders of skin and subcutaneous tissue

325

1902

1.44

8.99

1.1

2.87

6.69

nmol/l

1.61

356

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

298

1858

1.46

8.93

1.1

3.14

5.75

nmol/l

0.94

332

Hernia of abdominal wall, postoperative

399

2.07

8.91

1.1

0.70

6.18

nmol/l

2.55

Other spirochaetal diseases, including avohilmo

165

993

1.67

8.90

1.1

4.59

7.69

nmol/l

0.56

188

Coxarthrosis [arthrosis of hip](FG)

223

979

1.57

8.90

1.1

7.70

8.36

nmol/l

0.08

186

Diseases of arteries, arterioles and capillaries (FINNGEN)

101

354

1.97

8.85

1.1

0.57

10.49

nmol/l

1.15

Heartburn

237

2.42

8.85

1.1

8.40

12.36

nmol/l

0.21

Monoamine oxidase A inhibitors

268

2.33

8.84

1.1

1.17

14.19

nmol/l

—

Dental operations

248

824

1.55

8.83

1.1

8.35

7.01

nmol/l

0.18

171

Vasomotor and allergic rhinitis

171

1017

1.65

8.79

1.1

6.48

7.82

nmol/l

0.14

185

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

444

2047

1.37

8.75

1.1

5.12

5.98

nmol/l

0.17

376

Lyme disease, including avohilmo

161

968

1.67

8.73

1.1

4.59

7.99

nmol/l

0.61

177

Lyme disease

161

968

1.67

8.73

1.1

4.59

7.99

nmol/l

0.61

177

Tinnitus

119

657

1.82

8.72

1.2

1.1

1.40

9.92

nmol/l

2.18

122

Cholecystectomy

318

1877

1.44

8.71

1.1

6.16

6.28

nmol/l

0.02

324

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

260

1743

1.49

8.68

1.1

4.13

6.87

nmol/l

0.44

339

Gingivitis and periodontal diseases

431

1609

1.39

8.67

1.1

4.89

7.26

nmol/l

0.71

284

Inflammatory diseases of female pelvic organs

295

1376

1.47

8.66

1.1

1.18

6.53

nmol/l

2.48

240

Spirochaetal infections, other/unspecified, including avohilmo

162

978

1.66

8.65

1.1

4.59

7.88

nmol/l

0.59

183

Viral and other specified intestinal infections, including avohilmo

132

724

1.76

8.63

1.1

2.04

7.55

nmol/l

1.20

134

Thyrotoxicosis with diffuse goitre

355

2.13

8.59

1.1

2.77

10.31

nmol/l

0.72

Adenomyosis (Endometriosis of uterus)

303

2.22

8.56

1.1

9.16

6.48

nmol/l

—

Heart failure, not strict

321

1499

1.44

8.50

1.1

5.19

6.71

nmol/l

0.25

277

Mixed and other personality disorders

212

2.47

8.46

1.1

1.42

5.12

nmol/l

—

Other viral diseases, not elsewhere classified, including avohilmo

131

749

1.74

8.35

1.1

2.37

7.78

nmol/l

1.00

133

Other and unspecified effects of external causes

131

754

1.74

8.35

1.1

1.32

8.18

nmol/l

1.88

143

Weight loss

263

2.30

8.31

1.1

0.11

8.59

nmol/l

—

Polymyalgia rheumatica

301

2.21

8.31

1.1

3.49

14.03

nmol/l

—

Thyroiditis, ILD-related definition

308

2.19

8.28

1.1

8.28

8.23

nmol/l

—

Abnormal weight loss

245

2.35

8.27

1.1

0.11

8.91

nmol/l

—

Other diseases of anus and rectum

132

761

1.73

8.25

1.1

6.32

6.35

nmol/l

0.00

150

Atopic dermatitis

273

1482

1.47

8.23

1.1

2.52

7.00

nmol/l

1.53

258

Other disorders of the musculoskeletal system and connective tissue

388

2.05

8.23

1.2

1.1

6.61

11.31

nmol/l

0.35

Senile cataract

254

1029

1.50

8.18

1.1

10.80

7.00

nmol/l

0.47

184

Hernia

408

1979

1.37

8.14

1.1

4.70

6.10

nmol/l

0.37

356

Mouth breathing

179

1125

1.59

8.10

1.1

6.60

7.35

nmol/l

0.08

212

Other specified/unspecified dorsopathies

3.80

8.08

1.1

1.37

5.48

nmol/l

—

Polyarthrosis

417

1.95

8.07

1.1

6.80

10.56

nmol/l

0.27

Disorders of vitreous body

224

1411

1.51

8.02

1.1

12.49

5.89

nmol/l

0.43

265

Disorders of vitreous body and globe

229

1442

1.51

7.98

1.1

12.49

6.10

nmol/l

0.41

272

Noninflammatory disorders of female genital tract

172

523

1.65

7.97

1.2

1.1

6.16

5.74

nmol/l

0.03

Congenital malformations, deformations and chromosomal abnormalities

267

1738

1.46

7.97

1.1

3.69

5.99

nmol/l

0.68

309

Other diseases of lip and oral mucosa

194

1250

1.56

7.95

1.1

3.62

6.61

nmol/l

0.66

240

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

181

710

1.61

7.94

1.1

3.53

7.81

nmol/l

0.71

126

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

533

1.87

7.91

1.1

0.50

9.05

nmol/l

1.53

Genitourinary diseases

232

760

1.53

7.89

1.1

4.66

6.20

nmol/l

0.37

134

Internal derangement of knee

154

931

1.64

7.88

1.1

1.04

7.24

nmol/l

2.24

186

Plantar fascial fibromatosis

207

2.43

7.88

1.1

3.31

16.84

nmol/l

—

Zoster [herpes zoster], including avohilmo

229

1479

1.50

7.82

1.1

12.84

5.71

nmol/l

0.38

287

Fibroblastic disorders

521

1.87

7.81

1.1

2.10

11.32

nmol/l

2.03

107

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

239

2.32

7.80

1.2

1.1

0.21

7.79

nmol/l

—

Dental caries, including avohilmo

304

1079

1.44

7.78

1.1

5.46

8.25

nmol/l

0.60

209

Disorders of gallbladder, biliary tract and pancreas

436

2014

1.35

7.76

1.1

5.20

5.98

nmol/l

0.16

355

Polycystic ovarian syndrome, consortium definition

327

1327

1.42

7.69

1.1

5.81

5.77

nmol/l

0.01

235

Atrial fibrillation and flutter with reimbursement

104

353

1.86

7.61

1.1

7.07

9.92

nmol/l

0.17

Localized swelling, mass and lump of skin and subcutaneous tissue

143

866

1.66

7.61

1.2

1.1

3.29

8.91

nmol/l

1.51

161

Bleeding

354

1800

1.38

7.47

1.1

5.28

6.49

nmol/l

0.25

340

Other disorders of adrenal gland

125

2.83

7.44

1.2

1.1

0.26

1.25

nmol/l

—

Noninfective enteritis and colitis

206

1364

1.51

7.43

1.1

2.89

6.45

nmol/l

0.86

253

Other specified/unspecified soft tissue disorders

3.15

7.41

1.1

0.55

8.72

nmol/l

—

Disorders of speech understanding and production

3.16

7.41

1.2

1.1

4.92

1.91

nmol/l

—

Impingement syndrome of shoulder

531

1.83

7.38

1.1

5.90

10.18

nmol/l

0.36

106

Osteoporosis

117

621

1.74

7.33

1.1

4.65

9.18

nmol/l

0.54

124

Speech therapy

122

716

1.71

7.33

1.1

4.23

9.49

nmol/l

0.85

136

Disorders of sclera, cornea, iris and ciliary body

244

1682

1.45

7.27

1.1

5.24

6.11

nmol/l

0.13

322

Focal brain injury

4.15

7.27

1.0

1.1

1.68

0.17

nmol/l

—

Arthropathies in other diseases classified elsewhere

3.33

7.26

1.1

1.39

1.52

nmol/l

—

All kidney diseases

434

2184

1.33

7.26

1.1

3.16

6.49

nmol/l

1.61

103

375

Disorders of mineral metabolism

185

2.45

7.24

1.1

7.65

16.20

nmol/l

—

Procreative management

150

762

1.63

7.22

1.1

0.54

7.84

nmol/l

1.89

132

Injuries to the hip and thigh

207

1236

1.50

7.21

1.1

3.28

7.40

nmol/l

1.48

242

Fissure and fistula of anal and rectal regions

108

616

1.76

7.18

1.1

2.62

5.88

nmol/l

0.61

120

Other viral diseases, including avohilmo

172

1096

1.56

7.13

1.1

2.54

7.83

nmol/l

1.51

200

Benign neoplasm of other and ill-defined parts of digestive system

474

1.87

7.08

1.1

7.20

11.27

nmol/l

0.28

Complications of internal orthopaedic prosthetic devices, implants and grafts

553

1.80

7.08

1.1

3.08

10.27

nmol/l

1.38

115

Implicit fungal Sepsis

3.06

7.06

1.1

0.30

4.39

nmol/l

—

Conjunctivitis (acute, non atopic)

127

759

1.67

7.02

1.1

6.46

8.38

nmol/l

0.17

127

Caries of dentine, including avohilmo

322

1177

1.40

7.01

1.1

6.43

7.78

nmol/l

0.23

228

Abnormal findings on diagnostic imaging of lung

202

1279

1.50

6.99

1.1

3.44

7.43

nmol/l

1.42

246

Adrenocortical insufficiency

102

2.98

6.98

1.2

1.1

0.26

1.56

nmol/l

—

Benign neoplasm: Colon

231

1489

1.46

6.96

1.1

4.55

7.45

nmol/l

0.70

272

Cholelithiasis, broad definition with cholecystitis

378

1864

1.35

6.95

1.1

4.41

6.31

nmol/l

0.47

325

Aneurysms, operations, SAH

365

1.98

6.94

1.1

7.18

12.74

nmol/l

0.44

Sequelae of injuries, of poisoning and of other consequences of external causes

112

653

1.72

6.92

1.1

3.59

9.77

nmol/l

0.83

119

Spontaneous rupture of synovium and tendon

171

2.47

6.91

1.1

0.97

18.04

nmol/l

—

Bacterial infection, other or unspecified, including avohilmo

247

1406

1.44

6.87

1.1

6.46

6.81

nmol/l

0.05

260

Obesity due to excess calories

219

1497

1.47

6.85

1.1

3.15

6.79

nmol/l

0.93

273

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

135

831

1.63

6.79

1.1

7.21

6.64

nmol/l

0.04

151

Substance abuse, excluding more controls

210

1185

1.48

6.79

1.1

0.76

8.03

nmol/l

4.51

240

Viral infections characterized by skin and mucous membrane lesions

188

1248

1.51

6.77

1.1

2.25

6.77

nmol/l

1.71

239

Other and unspecified urticaria

539

1.79

6.77

1.1

0.77

9.40

nmol/l

1.80

104

Phobic anxiety disorders

293

2.09

6.77

1.1

1.13

4.74

nmol/l

0.96

Other and unspecified disorders of vitreous body

184

1190

1.52

6.75

1.1

15.60

5.59

nmol/l

0.55

223

Graves ophthalmopathy, strict

3.45

6.73

1.1

1.13

1.15

nmol/l

—

Cholelithiasis

364

1843

1.35

6.69

1.1

4.76

6.35

nmol/l

0.36

320

Postmenopausal osteoporosis with pathological fracture

150

2.56

6.69

1.0

1.1

2.01

18.79

nmol/l

—

Chronic gastritis

113

667

1.70

6.68

1.1

11.02

6.29

nmol/l

0.38

128

Bacterial infection, other or unspecified

224

1298

1.46

6.67

1.1

4.63

7.46

nmol/l

0.69

241

Unspecified haematuria

169

891

1.55

6.65

1.1

2.84

9.06

nmol/l

2.08

183

Dislocation, sprain and strain of joints and ligaments at neck level

435

1.87

6.61

1.2

1.1

5.59

5.54

nmol/l

0.00

Hypo-osmolality and hyponatraemia

405

1.89

6.52

1.1

3.18

11.22

nmol/l

1.09

Excessive attrition of teeth

275

1957

1.39

6.50

1.1

1.02

6.01

nmol/l

4.02

355

Speech and linguistic disorders

186

2.33

6.49

1.2

1.1

3.80

3.08

nmol/l

0.06

Fungal Sepsis

101

2.90

6.48

1.1

0.30

4.47

nmol/l

—

Ischaemic heart disease, wide definition

315

1410

1.38

6.47

1.1

6.38

6.65

nmol/l

0.03

277

Raynaud syndrome

253

2.15

6.47

1.1

7.63

6.90

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

175

1142

1.52

6.46

1.1

2.57

7.32

nmol/l

1.42

210

Inflammatory diseases of prostate (prostatitis)

266

2.12

6.46

1.2

1.1

3.42

6.28

nmol/l

0.54

Graves ophthalmopathy

3.26

6.45

1.1

1.13

0.89

nmol/l

—

Ovarian cyst

143

506

1.62

6.41

1.1

4.31

5.69

nmol/l

0.17

Other mental disorders due to brain damage and dysfunction and to physical disease

294

2.05

6.39

1.1

10.45

12.90

nmol/l

0.12

Carbimazole or st.post thyroidectomy, condition for graves disease

103

601

1.72

6.39

1.0

1.1

11.28

8.14

nmol/l

0.17

119

Other peripheral vertigo

229

2.20

6.34

1.1

0.48

13.88

nmol/l

—

Other noninfective gastroenteritis and colitis

111

662

1.68

6.33

1.1

1.10

9.35

nmol/l

2.23

127

Other symptoms and signs involving the urinary system

223

2.21

6.30

1.1

0.28

7.96

nmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

127

777

1.62

6.27

1.1

1.23

4.58

nmol/l

1.45

145

Abnormal findings on examination of blood, without diagnosis

196

1206

1.47

6.25

1.1

7.24

7.44

nmol/l

0.02

234

Conductive and sensorineural hearing loss

324

1585

1.36

6.23

1.1

3.55

7.31

nmol/l

1.24

310

Scleritis and episcleritis

156

2.46

6.19

1.2

1.1

6.16

4.49

nmol/l

—

MS-disease / Multiple Sclerosis

200

2.27

6.15

1.1

4.16

5.65

nmol/l

—

Caries of enamel

424

2131

1.30

6.11

1.1

1.47

6.45

nmol/l

4.12

370

Chronic diseases of tonsils and adenoids

327

1526

1.35

6.09

1.1

6.36

6.67

nmol/l

0.04

273

Nutritional anaemias

209

1381

1.45

6.09

1.1

4.74

7.67

nmol/l

0.57

260

Congenital malformations and deformations of the musculoskeletal system

206

2.23

6.08

1.1

1.23

3.04

nmol/l

—

Other medical care

195

1116

1.47

6.07

1.1

20.06

6.02

nmol/l

0.45

230

Ménière disease

214

2.21

6.06

1.1

0.29

8.80

nmol/l

—

Injuries to the wrist and hand

441

2263

1.29

6.03

1.1

2.00

6.41

nmol/l

3.40

397

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

272

2.06

6.02

1.1

0.96

4.72

nmol/l

—

Algoneurodystrophy

2.96

6.02

1.0

1.1

0.08

0.29

nmol/l

—

Diseases of the digestive system

186

1256

1.47

6.01

1.1

4.00

7.44

nmol/l

0.95

242

Periodontitis

432

2127

1.30

5.96

1.1

3.84

6.03

nmol/l

0.90

378

Herpesviral [herpes simplex] infections, including avohilmo

121

751

1.62

5.95

1.1

2.23

7.95

nmol/l

1.29

148

All influenza

111

674

1.65

5.95

1.2

1.1

3.60

9.09

nmol/l

0.96

129

Renal tubulo-interstitial diseases

371

2066

1.32

5.91

1.1

2.99

6.66

nmol/l

1.68

372

Chondrocostal junction syndrome [Tietze]

101

2.80

5.91

1.1

1.45

0.34

nmol/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

149

602

1.56

5.90

1.1

6.02

1.90

nmol/l

0.43

100

Specific development disorders of speech and language

119

2.61

5.88

1.2

1.1

4.48

1.45

nmol/l

0.30

Other skin changes

505

1.75

5.82

1.0

1.1

6.09

12.24

nmol/l

0.54

102

Other acute lower respiratory infections

221

1489

1.42

5.78

1.1

9.08

5.79

nmol/l

0.43

274

Viral and other specified intestinal infections

508

1.73

5.77

1.1

1.75

6.31

nmol/l

1.45

Other obstetric conditions, not elsewhere classified

152

622

1.55

5.76

1.1

1.67

1.86

nmol/l

0.05

102

Chronic periodontitis, including avohilmo

429

2124

1.29

5.74

1.1

3.88

6.04

nmol/l

0.88

377

Eating disorders

279

2.01

5.72

1.1

0.31

4.36

nmol/l

—

Covid-19 suspected case

100

598

1.68

5.71

1.1

1.15

6.38

nmol/l

2.62

113

Adverse effects, not elsewhere classified

553

1.71

5.71

1.1

0.80

9.15

nmol/l

1.68

103

Superficial injury of wrist and hand

576

1.69

5.69

1.1

1.96

9.88

nmol/l

1.32

104

Angina pectoris

219

1021

1.43

5.64

1.1

7.62

7.30

nmol/l

0.03

201

Other hearing loss

115

692

1.61

5.63

1.1

4.43

8.78

nmol/l

0.84

140

Injuries to the shoulder and upper arm

358

2107

1.31

5.62

1.1

4.59

6.04

nmol/l

0.38

388

Injuries to the knee and lower leg

508

2176

1.26

5.60

1.1

3.52

6.18

nmol/l

1.21

400

Statin medication

279

1147

1.37

5.58

1.1

5.79

4.48

nmol/l

0.19

211

Sequelae of external causes of morbidity and mortality

113

702

1.62

5.57

1.1

3.37

9.48

nmol/l

1.35

133

Other specified/unspecified inflammatory spondylopathies

2.82

5.57

1.2

1.1

2.87

4.78

nmol/l

—

Other specified/unspecified arthritis

106

648

1.64

5.57

1.1

0.31

9.52

nmol/l

2.61

128

Disorders of skin appendages

220

1560

1.41

5.57

1.1

2.47

6.52

nmol/l

1.64

303

Other and unspecified drugs and medicaments

229

2.11

5.54

1.3

1.1

0.21

5.82

nmol/l

—

Achilles tendinitis

229

2.11

5.54

1.1

0.54

15.22

nmol/l

1.38

Injuries to the abdomen, lower back, lumbar spine and pelvis

168

1126

1.47

5.48

1.1

1.83

7.08

nmol/l

2.02

223

Other disorders of conjunctiva

347

1.88

5.48

1.1

1.54

12.52

nmol/l

—

Disorders of choroid and retina

332

1758

1.32

5.48

1.1

4.29

6.79

nmol/l

0.62

344

Injuries to the ankle and foot

317

2043

1.33

5.47

1.1

1.80

5.66

nmol/l

2.32

363

Sensorineural hearing loss

302

1501

1.34

5.46

1.1

3.44

7.84

nmol/l

1.41

288

Other arthritis (FG)

123

784

1.57

5.45

1.1

0.36

9.15

nmol/l

3.01

148

Hyperplasia of prostate

133

475

1.58

5.45

1.1

6.85

6.71

nmol/l

0.02

Systemic lupus erythematosus

2.84

5.42

1.1

0.36

0.90

nmol/l

—

Budesonide

349

1.87

5.38

1.1

2.15

11.20

nmol/l

0.82

Biomechanical lesions, not elsewhere classified

136

2.45

5.38

1.0

1.1

13.39

3.38

nmol/l

—

Misadventures to patients during surgical and medical care

378

1.83

5.37

1.1

1.64

12.78

nmol/l

—

Presence of other functional implants

239

1180

1.39

5.36

1.1

5.23

7.97

nmol/l

0.60

231

Graves disease, strict definition

294

1.95

5.34

1.1

5.30

5.47

nmol/l

—

Dermatographic urticaria

194

2.18

5.28

1.1

0.15

5.16

nmol/l

—

Other symptoms and signs involving the circulatory and respiratory systems

131

2.46

5.28

1.0

1.1

18.68

8.03

nmol/l

—

False labour

135

540

1.56

5.28

1.1

1.90

3.27

nmol/l

0.28

Other specified and unspecified personality disorders

234

2.06

5.26

1.1

0.44

5.22

nmol/l

1.31

Diabetic neuropathy

226

2.08

5.26

1.1

3.45

6.43

nmol/l

0.50

Valvular heart disease excluding rheumatic fever

184

909

1.45

5.25

1.0

1.1

10.07

8.44

nmol/l

0.13

165

Non-rheumatic valve diseases

183

903

1.45

5.24

1.0

1.1

10.07

8.59

nmol/l

0.12

162

Other and unspecified tonsillitis

137

747

1.53

5.21

1.1

6.77

3.44

nmol/l

0.32

137

Other necrotizing vasculopathies (FG)

132

2.44

5.21

1.1

0.16

19.81

nmol/l

—

Striking against or struck by other objects

142

943

1.51

5.21

1.1

1.59

7.81

nmol/l

2.23

174

Coxarthrosis, primary

236

1425

1.38

5.20

1.1

6.82

6.91

nmol/l

0.01

269

Sacrococcygeal disorders, not elsewhere classified

3.25

5.18

1.1

0.84

1.51

nmol/l

—

Adhesive capsulitis of shoulder

361

1.84

5.17

1.0

1.1

1.47

14.15

nmol/l

1.99

Chondropathies

405

1.79

5.16

1.1

0.71

7.56

nmol/l

2.67

Fracture of skull and facial bones

555

1.66

5.13

1.1

3.57

10.20

nmol/l

1.01

106

Endometriosis of ovary

388

1.78

5.12

1.1

8.44

5.80

nmol/l

0.18

Attention to artificial openings

2.74

5.11

1.1

1.2

—

8.91

—

Other noninflammatory disorders of vulva and perineum

210

2.11

5.10

1.1

0.15

7.30

nmol/l

—

Superficial injury of hip and thigh

370

1.82

5.09

1.1

0.09

11.98

nmol/l

—

Spondylopathies (FG)

321

1.88

5.05

1.2

1.1

2.11

12.92

nmol/l

1.10

Other peripheral vascular diseases

211

2.10

5.05

1.1

10.53

7.83

nmol/l

—

Acute bronchitis

166

1125

1.45

5.03

1.1

8.29

6.39

nmol/l

0.21

211

Encephalitis

2.84

5.00

1.1

0.09

1.57

nmol/l

—

Iron deficiency anaemia

178

1224

1.43

4.99

1.1

4.37

6.86

nmol/l

0.40

231

Benign neoplasm of brain and other parts of central nervous system

160

2.27

4.98

1.2

1.1

0.09

3.08

nmol/l

—

Type of accident

124

810

1.54

4.97

1.1

6.66

8.61

nmol/l

0.15

157

Dermatopolymyositis (FG)

5.10

4.97

1.1

0.11

0.28

nmol/l

—

Gout

517

1.63

4.97

1.1

4.29

8.59

nmol/l

0.62

106

Diseases of tongue

129

2.42

4.96

1.1

22.73

19.03

nmol/l

—

Artrosis, including avohilmo

340

1427

1.31

4.94

1.1

13.28

4.23

nmol/l

0.87

259

Paralytic ileus and intestinal obstruction

100

622

1.61

4.94

1.1

1.03

6.54

nmol/l

3.87

122

Hypokalaemia

289

1.91

4.90

1.1

10.40

15.04

nmol/l

—

Mycoses

122

797

1.54

4.90

1.1

6.69

9.15

nmol/l

0.26

145

Asthma mixed form (mode), excluding more controls

2.79

4.87

1.1

1.12

9.83

nmol/l

—

Other bursopathies

276

1.93

4.85

1.1

9.41

15.85

nmol/l

0.34

Superficial injury of lower leg

113

730

1.55

4.78

1.1

1.47

8.27

nmol/l

1.80

139

Asthma mixed form (mode)

2.75

4.77

1.1

1.12

14.79

nmol/l

—

Endometriosis ASRM stages 1,2

506

1.67

4.75

1.1

1.43

8.21

nmol/l

0.95

Acute laryngitis and tracheitis

267

1.92

4.73

1.1

5.74

4.19

nmol/l

0.12

Fitting and adjustment of other devices

141

840

1.48

4.72

1.0

1.1

9.40

6.64

nmol/l

0.26

176

Herpesviral [herpes simplex] infections

329

1.83

4.71

1.0

1.1

3.66

6.79

nmol/l

—

Eating disorder

237

1.99

4.71

1.1

0.08

4.64

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

124

821

1.51

4.70

1.1

0.63

8.34

nmol/l

2.49

148

Early lumbar disc prolapse, operated

184

2.13

4.68

1.1

0.10

3.18

nmol/l

—

Memory loss

211

2.05

4.67

1.1

2.07

10.16

nmol/l

—

Acute pharyngitis

348

1.80

4.66

1.1

2.43

4.84

nmol/l

0.41

Artificial joint operation, meniscal resection

367

1840

1.28

4.65

1.1

6.83

6.13

nmol/l

0.11

349

Trigger finger

316

1.84

4.64

1.1

2.71

14.76

nmol/l

—

Schizophrenia or delusion, excluding more controls

103

648

1.57

4.63

1.1

2.77

9.46

nmol/l

1.39

126

Abnormal serum enzyme levels

121

771

1.52

4.62

1.1

6.60

6.49

nmol/l

0.01

157

Colonic or urogenital fistula

116

761

1.53

4.60

1.1

2.62

9.40

nmol/l

1.19

142

Other and unspecified iron deficiency

140

953

1.47

4.59

1.1

5.44

7.89

nmol/l

0.30

179

Benign neoplasm: Rectum, anus and anal canal

535

1.63

4.56

1.1

5.43

10.11

nmol/l

0.34

111

Dementia in other diseases classified elsewhere

110

2.48

4.55

1.0

1.2

0.09

6.81

nmol/l

—

Presbyopia

180

2.12

4.53

1.1

1.30

3.41

nmol/l

—

Other/unspecified synovitis and tenosynovitis

241

1.96

4.52

1.1

0.10

17.74

nmol/l

—

Other hammer toe(s) (acquired)

335

1.77

4.52

1.1

1.0

6.40

12.28

nmol/l

0.33

Coronary atherosclerosis

242

1135

1.35

4.50

1.1

10.87

6.95

nmol/l

0.52

225

Superficial injury of abdomen, lower back and pelvis

408

1.72

4.49

1.1

3.03

8.50

nmol/l

—

Other encephalitis

2.80

4.46

1.1

0.09

1.57

nmol/l

—

Diseases of arteries, arterioles and capillaries

259

1434

1.33

4.46

1.1

3.49

7.92

nmol/l

1.43

274

Other complications of surgical and medical care, not elsewhere classified

236

1.96

4.43

1.1

3.34

8.19

nmol/l

—

Dermatophytosis, including avohilmo

274

2058

1.31

4.41

1.1

7.88

5.68

nmol/l

0.34

372

Flat foot [pes planus] (acquired)

209

2.02

4.41

1.1

0.16

12.30

nmol/l

—

Disorders of calcium metabolism

143

2.25

4.40

1.1

8.71

9.38

nmol/l

—

Divergent concomitant strabismus

156

2.19

4.39

1.1

—

7.11

nmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

176

2.11

4.37

1.1

0.21

3.42

nmol/l

—

Unspecified fall

205

1482

1.36

4.35

1.0

1.1

3.16

6.38

nmol/l

1.00

274

Open wound of head

211

1465

1.35

4.35

1.1

6.07

6.88

nmol/l

0.10

277

Benign neoplasm: Pituitary gland, craniopharyngeal duct

144

2.24

4.35

1.0

1.1

1.62

3.29

nmol/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.91

4.34

1.2

1.0

7.57

1.52

nmol/l

—

Poisoning by drugs, medicaments and biological substances

103

668

1.55

4.33

1.1

3.97

5.08

nmol/l

0.11

119

Other diseases of liver

489

1.64

4.31

1.1

9.16

10.85

nmol/l

0.09

Visual field defects

138

2.26

4.31

1.1

0.12

8.56

nmol/l

—

Other/unspecified disorders of vestibular function

101

2.50

4.30

1.0

1.1

1.38

5.29

nmol/l

—

Venous thromboembolism

208

1483

1.35

4.27

1.1

4.69

7.14

nmol/l

0.55

280

Necrosis of pulp, including avohilmo

250

1881

1.32

4.25

1.1

3.33

6.01

nmol/l

0.74

340

Unspecified mental disorder

162

1154

1.41

4.24

1.1

4.48

6.81

nmol/l

0.33

216

Dermatopolymyositis

4.20

4.23

1.1

0.11

0.08

nmol/l

—

Atopic dermatitis, strict definition with reimbursement

123

799

1.48

4.23

1.1

3.86

7.75

nmol/l

0.46

142

SLE, ICD10

2.53

4.23

1.1

0.36

0.79

nmol/l

—

SLE, strict definition

2.53

4.23

1.1

0.36

0.79

nmol/l

—

Other retinal disorders

251

1447

1.32

4.22

1.1

3.12

7.16

nmol/l

1.24

288

Benign neoplasm of other and unspecified endocrine glands

356

1.75

4.22

1.1

6.31

13.11

nmol/l

0.49

Poisoning by medicine

602

1.57

4.19

1.1

3.97

4.51

nmol/l

0.05

108

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

123

835

1.48

4.18

1.0

1.1

1.53

8.75

nmol/l

2.32

155

Benign neoplasm: Rectum

479

1.63

4.15

1.2

1.1

5.87

10.56

nmol/l

0.31

100

Acute tubulo-interstitial nephritis

255

1645

1.31

4.14

1.1

3.91

7.42

nmol/l

1.04

308

Other female pelvic inflammatory diseases

449

1.65

4.13

1.1

1.18

11.50

nmol/l

—

Childhood asthma (age<16), excluding more controls

192

1.92

4.12

1.2

1.1

0.66

6.14

nmol/l

—

Benign thyroid growths and nodules

125

792

1.47

4.12

1.1

5.55

7.65

nmol/l

0.21

153

Supplementary factors related to causes of morbidity and mortality classified elsewhere

129

887

1.46

4.12

1.1

6.17

8.26

nmol/l

0.19

171

Episcleritis

135

2.24

4.09

1.1

6.16

4.02

nmol/l

—

Abnormal findings on diagnostic imaging of other body structures

382

1.71

4.09

1.0

1.1

7.23

11.60

nmol/l

—

Allergic rhinitis

130

885

1.45

4.08

1.1

6.26

6.88

nmol/l

0.05

165

Other disorders of bladder

265

1.86

4.07

1.1

1.98

13.20

nmol/l

1.20

Transport accidents

183

1112

1.37

4.05

1.1

3.54

8.56

nmol/l

1.40

198

Childhood asthma (age<16)

194

1.90

4.01

1.2

1.1

0.66

6.14

nmol/l

—

Gonarthrosis,primary

357

1718

1.25

3.94

1.1

5.86

6.56

nmol/l

0.12

319

Other bacterial intestinal infections, including avohilmo

621

1.53

3.90

1.1

0.93

9.55

nmol/l

2.18

119

Pregnancy examination and test

258

1.69

3.89

1.1

1.10

5.28

nmol/l

—

Congenital malformations of the circulatory system

355

1.70

3.85

1.1

7.35

5.86

nmol/l

—

Hypermetropia

145

2.15

3.85

1.1

0.66

4.13

nmol/l

—

Systemic lupus erythematosus, unspecified

2.56

3.81

1.1

0.42

0.90

nmol/l

—

Other gastritis (incl. Duodenitis)

561

1.56

3.81

1.1

0.68

8.40

nmol/l

1.74

108

Autoimmune hepatitis, wide definition

2.49

3.80

1.1

10.76

0.12

nmol/l

—

Tracheo-bronchomalasia

12.32

3.78

1.2

1.0

—

Other noninflammatory disorders of uterus, except cervix

338

1.60

3.77

1.1

3.80

6.96

nmol/l

0.38

Keratitis

145

1037

1.40

3.77

1.1

2.85

6.82

nmol/l

1.27

199

Hallux valgus (acquired)

123

605

1.46

3.76

1.1

5.34

10.13

nmol/l

0.49

116

Recurrent aphthous stomatitis , including avohilmo

392

1.66

3.74

1.1

2.86

14.09

nmol/l

1.51

Fall on same level involving ice and snow

234

1801

1.30

3.73

1.1

2.23

6.42

nmol/l

2.07

334

Hyperparathyroidism

441

1.62

3.73

1.1

1.16

11.42

nmol/l

1.78

Myocarditis

2.41

3.72

1.0

1.1

0.40

21.04

nmol/l

—

Diseases of male genital organs

170

619

1.38

3.70

1.1

4.91

5.68

nmol/l

0.17

117

Dislocation, sprain and strain of joints and ligaments of knee

255

1795

1.29

3.69

1.1

3.58

6.01

nmol/l

0.77

337

Open wound of lower leg

394

1.66

3.68

1.1

5.66

13.29

nmol/l

0.76

Familial hypercholesterolemia

326

1.72

3.68

1.1

4.28

12.07

nmol/l

0.91

Suicide or other Intentional self-harm

101

679

1.49

3.66

1.1

4.21

7.77

nmol/l

0.34

126

Type 2 diabetes, wide definition

318

1597

1.26

3.63

1.1

5.60

6.35

nmol/l

0.13

303

conjunctival haemorrhage

190

1.96

3.62

1.2

1.1

0.25

5.77

nmol/l

—

Reactive arthropathies

183

1.98

3.62

1.2

1.1

0.13

16.41

nmol/l

—

Female genital prolapse

106

393

1.50

3.62

1.1

21.39

6.25

nmol/l

0.42

Disorders of breast

206

1376

1.32

3.61

1.1

1.92

6.45

nmol/l

1.59

239

Early onset COPD, excluding more controls

411

1.63

3.61

1.0

1.1

8.63

10.69

nmol/l

0.12

Unknown and unspecified causes of morbidity

123

2.20

3.60

1.0

1.1

9.37

13.37

nmol/l

—

Nummular dermatitis

198

1.93

3.57

1.1

7.40

8.22

nmol/l

—

Recurrent dislocation and subluxation of joint

150

2.08

3.56

1.1

0.21

3.74

nmol/l

—

Special screening examination for other diseases and disorders

191

1.94

3.55

1.1

16.60

14.97

nmol/l

—

Other menopausal disorders

106

396

1.50

3.54

1.0

1.1

2.30

5.64

nmol/l

0.60

Maternal care for other conditions predominantly related to pregnancy

611

1.50

3.54

1.1

0.11

2.79

nmol/l

1.06

Amenorrhoea

124

2.19

3.54

1.1

0.11

5.93

nmol/l

—

Endometriosis ASRM stages 3,4

653

1.49

3.51

1.1

9.09

7.17

nmol/l

0.13

117

Postmenopausal bleeding

334

1.52

3.50

1.1

5.02

6.06

nmol/l

0.09

Erysipelas

215

1422

1.30

3.49

1.0

1.1

3.82

7.23

nmol/l

1.15

260

Chalazion

250

1.81

3.48

1.0

1.1

10.66

4.66

nmol/l

—

Special screening examination for neoplasms

106

2.27

3.45

1.0

1.1

16.22

7.93

nmol/l

—

Other bacterial intestinal infections

448

1.59

3.45

1.1

1.13

11.76

nmol/l

1.87

Sequelae with surgical and medical care as external cause

543

1.53

3.44

1.1

3.13

11.30

nmol/l

1.47

104

Other and unspecified mood [affective] disorders

166

2.00

3.43

1.2

1.1

0.11

6.31

nmol/l

—

Use of selegiline

100

2.32

3.43

1.1

2.22

4.34

nmol/l

—

Other necrotizing vasculopathies

173

1.98

3.43

1.1

0.16

9.42

nmol/l

—

Erysipelas, including avohilmo

290

1712

1.26

3.41

1.1

5.53

6.21

nmol/l

0.11

322

Disorders of parathyroid gland

514

1.54

3.41

1.1

1.05

10.36

nmol/l

1.92

103

Other disorders of breast

388

1.63

3.39

1.1

0.11

12.91

nmol/l

—

Other condition

388

1.63

3.38

1.1

14.56

7.83

nmol/l

—

All influenza (not pneumonia)

365

1.65

3.38

1.1

4.81

8.81

nmol/l

0.56

Vestibular neuronitis

224

1.84

3.36

1.0

1.1

0.09

7.48

nmol/l

—

Other aneurysm

114

2.21

3.35

1.1

2.39

4.85

nmol/l

—

Atopic dermatitis, strict definition

120

831

1.41

3.33

1.1

3.86

6.86

nmol/l

0.34

156

Pulmonary heart disease

112

785

1.43

3.31

1.1

5.04

8.89

nmol/l

0.55

153

Other specified/unspecified spondylopathies

2.94

3.31

1.1

2.67

6.33

nmol/l

—

Glaucoma

210

1377

1.30

3.27

1.1

7.38

7.61

nmol/l

0.02

274

Pulmonary embolism

112

788

1.42

3.25

1.1

5.04

8.89

nmol/l

0.55

153

Rheumatoid arthritis

110

681

1.43

3.24

1.1

2.55

9.31

nmol/l

1.32

129

Kela-code for severe mental illness

138

1007

1.37

3.24

1.1

5.03

7.18

nmol/l

0.26

190

Inflammatory diseases of the central nervous system

220

1.83

3.22

1.1

0.10

3.77

nmol/l

—

Conduction disorders

109

609

1.44

3.22

1.1

5.40

9.00

nmol/l

0.46

111

Hernia of abdominal wall

176

1336

1.32

3.19

1.1

1.07

7.30

nmol/l

3.71

246

Noninfectious colitis NAS

356

1.63

3.18

1.1

2.09

12.95

nmol/l

—

Sequelae of injuries of upper limb

258

1.75

3.17

1.0

1.1

0.10

5.51

nmol/l

—

Inflammatory bowel disease

124

894

1.39

3.15

1.0

1.1

5.32

7.64

nmol/l

0.21

169

Reactive arthropathies, FINNGEN

158

1.97

3.14

1.2

1.1

0.13

2.01

nmol/l

—

Overexertion and strenuous or repetitive movements

252

1.75

3.12

1.2

1.1

10.24

5.94

nmol/l

—

Malignant neoplasm of digestive organs

879

0.67

3.10

1.1

6.14

7.13

nmol/l

0.09

165

Other abnormal uterine and vaginal bleeding

390

1.51

3.10

1.1

1.18

6.00

nmol/l

1.79

Other and unspecified anaemias

156

1098

1.34

3.06

1.1

5.09

7.66

nmol/l

0.39

222

Malignant neoplasm of bronchus and lung, including Hilmo

458

0.53

3.06

1.1

1.0

2.54

8.42

nmol/l

—

Degeneration of macula and posterior pole

172

1006

1.32

3.06

1.1

2.83

8.14

nmol/l

1.40

214

Outcome of delivery

269

1.58

3.05

1.1

0.17

5.06

nmol/l

—

Hallux rigidus

307

1.67

3.03

1.1

1.27

13.27

nmol/l

—

Pollen allergy

507

1.50

2.95

1.1

0.09

3.05

nmol/l

1.92

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

411

1.56

2.93

1.1

6.60

12.57

nmol/l

—

Other anaemias

156

1103

1.33

2.93

1.1

5.09

7.66

nmol/l

0.39

222

Brain meningioma, including Hilmo

135

2.01

2.91

1.1

2.09

11.52

nmol/l

—

Psychotic depression

108

2.14

2.90

1.0

1.1

11.55

11.25

nmol/l

—

Primary open-angle glaucoma

111

768

1.39

2.87

1.1

1.82

8.97

nmol/l

2.29

154

Spondyloarthritis

438

1.53

2.85

1.2

1.1

2.11

11.68

nmol/l

1.39

Mental disorders, not otherwise specified

222

1.76

2.85

1.1

0.28

5.98

nmol/l

—

Additional codes for the location of defect, injury or illness

150

1.94

2.85

1.1

2.03

2.56

nmol/l

—

Aplastic and other anaemias

166

1163

1.31

2.84

1.1

5.27

7.55

nmol/l

0.35

230

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

136

1.99

2.83

1.1

3.69

11.48

nmol/l

—

Drug-induced osteoporosis with pathological fracture

2.80

2.83

1.2

0.64

1.19

nmol/l

—

Intestinal stricture

116

844

1.38

2.83

1.1

17.96

6.82

nmol/l

0.28

167

Diseases of external ear

136

1015

1.34

2.82

1.1

4.52

7.31

nmol/l

0.38

197

Macular pucker

400

1.56

2.81

1.1

4.13

12.29

nmol/l

—

Glucosamine medication

166

1014

1.31

2.80

1.1

9.76

7.31

nmol/l

0.27

191

Abscess of anal and rectal regions

201

1.80

2.80

1.2

1.1

6.72

5.59

nmol/l

—

Melanocytic naevi

125

922

1.36

2.80

1.1

2.34

7.74

nmol/l

1.48

174

Open wound of wrist and hand

173

1291

1.30

2.80

1.1

2.13

7.24

nmol/l

2.25

236

Persons encountering health services in circumstances related to reproduction

220

1167

1.26

2.79

1.1

0.78

7.23

nmol/l

2.80

198

Bacterial pneumonia (organism specified)

161

1115

1.31

2.78

1.1

6.01

7.43

nmol/l

0.18

216

Sudden idiopathic hearing loss

254

1.70

2.77

1.0

1.1

3.00

16.46

nmol/l

—

Other specified and unspecified disorders of eyelid

3.28

2.74

1.1

—

2.22

—

Lesion of lateral popliteal nerve

111

2.08

2.73

1.1

0.13

6.00

nmol/l

—

Appendectomy

258

1995

1.23

2.73

1.1

3.53

5.84

nmol/l

0.82

365

Zoster [herpes zoster]

492

1.49

2.72

1.1

2.17

10.28

nmol/l

—

106

Organic, including symptomatic, mental disorders

184

1007

1.29

2.71

1.0

1.1

6.07

8.24

nmol/l

0.29

202

L04AA Selective immunosuppressants

624

1.43

2.71

1.2

1.1

4.08

9.99

nmol/l

0.98

113

DVT of lower extremities and pulmonary embolism

154

1173

1.31

2.70

1.1

5.09

7.68

nmol/l

0.46

228

Diabetic retinopathy, excluding more controls

348

1.45

2.68

1.1

0.50

6.69

nmol/l

2.57

Excessive vomiting in pregnancy

219

1.74

2.68

1.1

0.09

2.22

nmol/l

—

Exposure to other and unspecified animate mechanical forces

2.19

2.68

1.2

1.1

1.31

0.32

nmol/l

—

Melanocytic naevi of trunk

342

1.58

2.67

1.1

2.73

7.71

nmol/l

—

L02BB Anti-androgens

199

0.35

2.65

1.1

—

9.87

—

Corns and callosities

176

1.83

2.64

1.1

0.09

9.98

nmol/l

—

Other viral diseases

109

793

1.37

2.63

1.1

1.81

7.98

nmol/l

1.57

141

Candidiasis

407

1.53

2.62

1.1

4.13

12.02

nmol/l

0.87

Primary open-angle glaucoma, strict

636

1.41

2.59

1.1

1.47

8.94

nmol/l

2.05

133

Reimbursement for rheumatic diseases

215

1714

1.25

2.59

1.1

3.56

6.34

nmol/l

0.62

320

Collagenous colitis

252

1.67

2.58

1.1

0.54

14.55

nmol/l

1.54

Focal epilepsy, mode (most common among epilepsy diagnosis)

474

1.48

2.56

1.1

0.13

11.61

nmol/l

—

102

Bacterial pneumonia, not elsewhere classified

141

942

1.32

2.55

1.1

5.92

7.67

nmol/l

0.19

175

Tongue abnormality

171

1.82

2.54

1.1

22.73

6.24

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

261

1.65

2.53

1.1

4.66

8.20

nmol/l

—

Bacterial pneumoniae

147

989

1.31

2.53

1.1

6.21

7.84

nmol/l

0.19

182

Umbilical hernia

102

743

1.38

2.51

1.1

1.16

9.93

nmol/l

2.87

143

Fracture of shoulder and upper arm

130

982

1.32

2.50

1.1

4.65

7.94

nmol/l

0.57

193

Unstable angina pectoris

126

742

1.34

2.50

1.1

1.04

8.50

nmol/l

2.60

152

Alcohol abuse, main dg, excluding more controls

309

1.59

2.48

1.2

1.1

1.01

8.47

nmol/l

—

Benign neoplasm: Colon, unspecified

669

1.39

2.48

1.1

6.98

9.27

nmol/l

0.21

127

Lesion of sciatic nerve

2.21

2.47

1.1

0.21

5.18

nmol/l

—

Cardiac murmurs and other cardiac sounds

185

1.77

2.47

1.1

0.09

14.24

nmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

114

849

1.34

2.45

1.1

4.84

8.72

nmol/l

0.59

162

Scabies, including avohilmo

398

1.51

2.44

1.2

1.1

0.44

4.93

nmol/l

2.16

Pediculosis, acariasis and other infestations, including avohilmo

480

1.46

2.43

1.2

1.1

0.42

5.54

nmol/l

2.44

Diseases of liver

130

989

1.32

2.42

1.1

7.23

7.72

nmol/l

0.04

183

Malignant neoplasm of oesophagus

0.00

2.42

0.0

1.1

—

8.59

—

Primary hyperparathyroidism

288

1.60

2.41

1.1

2.19

14.29

nmol/l

—

Social phobias

189

1.75

2.40

1.1

0.23

5.98

nmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

473

1.46

2.40

1.1

7.26

12.03

nmol/l

—

Tonsillectomy and adenotomy

223

1256

1.24

2.40

1.1

2.20

6.39

nmol/l

1.32

213

Use of rivastigmine

335

1.55

2.39

1.0

1.1

6.24

13.08

nmol/l

—

Open wound of hip and thigh

2.08

2.37

1.2

5.57

0.94

nmol/l

—

Focal epilepsy, strict definition

508

1.44

2.35

1.1

0.12

11.33

nmol/l

—

105

Mental and behavioural disorders due to psychoactive substance use

220

1639

1.23

2.35

1.1

0.76

7.38

nmol/l

5.22

305

Focal epilepsy

558

1.42

2.35

1.1

0.12

10.23

nmol/l

—

117

Valvular operations

330

1.55

2.34

1.1

0.13

8.85

nmol/l

—

AV-block

363

1.49

2.33

1.0

1.1

4.39

12.62

nmol/l

0.99

Iridocyclitis

610

1.40

2.32

1.1

12.10

9.62

nmol/l

—

117

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

500

0.58

2.32

1.1

1.0

7.70

7.33

nmol/l

—

103

Bitten or struck by other mammals

323

1.55

2.31

1.1

0.67

6.25

nmol/l

1.58

Rash and other nonspecific skin eruption

237

1.65

2.31

1.1

4.96

6.72

nmol/l

0.20

Acne, including avohilmo

505

1.40

2.31

1.1

3.32

4.00

nmol/l

—

Glaucoma suspect

131

1005

1.30

2.31

1.1

10.99

8.34

nmol/l

0.14

195

Malignant neoplasm of heart, mediastinum and pleura

2.98

2.29

1.1

2.05

6.79

nmol/l

—

Other viral diseases, not elsewhere classified

493

1.44

2.29

1.1

1.31

7.59

nmol/l

—

Coeliac disease

324

1.55

2.29

1.2

1.1

3.51

8.86

nmol/l

—

Stomatitis and related lesions

553

1.41

2.29

1.1

2.22

10.77

nmol/l

1.58

104

Major coronary heart disease event excluding revascularizations

209

1115

1.24

2.27

1.1

5.14

7.30

nmol/l

0.38

216

Dysplasia of cervi uteri

433

1.40

2.27

1.1

0.26

6.43

nmol/l

2.34

Coxarthrosis, primary, with hip surgery

163

1195

1.27

2.26

1.1

9.42

7.46

nmol/l

0.27

222

Acute and subacute iridocyclitis

505

1.43

2.25

1.1

15.27

9.88

nmol/l

—

101

Superficial injury of ankle and foot

334

1.53

2.23

1.0

1.1

1.67

4.73

nmol/l

0.87

Benign neoplasm: Sigmoid colon

506

1.43

2.23

1.1

8.71

10.68

nmol/l

0.12

105

Anorexia (incl.atypical)

142

1.84

2.22

1.2

1.1

0.45

7.84

nmol/l

—

Other congenital malformations, including avohilmo

343

1.52

2.20

1.2

1.1

0.79

7.84

nmol/l

2.15

Primary gonarthrosis, bilateral

186

1253

1.24

2.20

1.1

7.22

6.82

nmol/l

0.04

241

Bacterial intestinal infections, IBD co-morbidities

466

1.44

2.19

1.1

0.46

12.19

nmol/l

2.61

Erosion of teeth , including avohilmo

105

788

1.33

2.19

1.1

3.03

7.02

nmol/l

0.92

154

Abrasion of teeth

143

1121

1.28

2.17

1.1

4.45

7.83

nmol/l

0.43

216

Allergic contact dermatitis

369

1.49

2.16

1.1

1.03

14.06

nmol/l

—

Other or unspecified ileus, impaction or obstruction

426

1.46

2.16

1.1

0.66

6.04

nmol/l

—

Inflammatory disease of uterus

402

1.47

2.15

1.1

0.12

11.82

nmol/l

—

Excessive earwax

237

1779

1.21

2.14

1.1

2.28

7.04

nmol/l

2.85

321

Primary_lymphoid and hematopoietic malignant neoplasms

611

1.38

2.14

1.0

1.1

0.11

10.27

nmol/l

—

128

Secondary hypertension

149

1.79

2.14

1.1

0.66

18.75

nmol/l

—

Nontoxic multinodular goitre

477

1.43

2.14

1.0

1.1

2.89

9.92

nmol/l

1.06

Non-Hodgkin lymphoma, all, including Hilmo

331

1.51

2.10

1.0

1.1

0.12

10.05

nmol/l

—

Unspecified event, undetermined intent

2.15

2.09

1.2

1.1

1.09

1.27

nmol/l

—

Vitamin deficiency, wide

124

1.86

2.07

1.2

1.1

0.10

4.22

nmol/l

—

Vitamin deficiency

124

1.86

2.07

1.2

1.1

0.10

4.22

nmol/l

—

Liquid cancers

108

777

1.32

2.06

1.1

2.58

6.84

nmol/l

0.85

149

Fracture of femur

585

1.36

2.04

1.1

3.78

10.33

nmol/l

1.25

122

Injury of muscle and tendon at lower leg level

399

1.46

2.04

1.1

5.52

7.42

nmol/l

0.23

Supervision of high-risk pregnancy

326

1.40

2.02

1.2

1.1

2.56

4.22

nmol/l

—

Other diseases of oesophagus

231

1.61

2.01

1.0

1.1

20.77

4.11

nmol/l

—

Heart failure and antihypertensive medication

370

1.39

2.01

1.1

7.96

4.32

nmol/l

0.23

Ulcerative colitis

670

1.35

2.01

1.1

2.08

9.07

nmol/l

1.62

129

Protozoal diseases, including avohilmo

2.02

2.01

1.0

1.2

—

1.89

—

Gout, idiopatic and unspecified

636

1.35

2.00

1.1

4.50

9.69

nmol/l

0.94

130

Substance abuse

210

1612

1.21

1.99

1.1

0.76

6.69

nmol/l

4.79

300

Long labour

660

0.69

1.97

1.1

0.12

4.48

nmol/l

—

105

Malignant neoplasm of digestive organs, including Hilmo

947

0.76

1.97

1.1

1.0

4.88

7.13

nmol/l

0.30

171

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

370

1.46

1.95

1.1

1.40

12.57

nmol/l

—

Unspecified acute lower respiratory infection

403

1.44

1.95

1.1

9.95

7.66

nmol/l

—

Event of undetermined intent

164

1.71

1.94

1.2

1.1

8.37

4.54

nmol/l

—

Seronegative rheumatoid arthritis

257

1.56

1.94

1.1

2.34

12.80

nmol/l

—

Nasal polyp

462

1.41

1.93

1.1

5.53

11.41

nmol/l

0.73

Postmenopausal atrophic vaginitis

353

1.36

1.93

1.1

0.39

6.63

nmol/l

2.20

Other maternal disorders predominantly related to pregnancy

216

1118

1.21

1.93

1.1

3.29

6.07

nmol/l

0.44

192

Seropositive rheumatoid arthritis

586

1.36

1.92

1.1

2.95

9.73

nmol/l

1.06

107

Other superficial mycoses, including avohilmo

290

1.52

1.92

1.1

8.52

4.78

nmol/l

—

Diabetic maculopathy, excluding more controls

258

1.55

1.91

1.0

1.1

0.55

7.23

nmol/l

—

Periapical abscess

178

1456

1.22

1.90

1.1

4.51

6.89

nmol/l

0.48

261

Gout, FINNGEN

741

1.32

1.90

1.1

4.29

9.22

nmol/l

1.05

157

Other and unspecified rosacea

251

1.56

1.89

1.1

6.94

7.97

nmol/l

—

Gonarthrosis, primary, with knee surgery

202

1299

1.21

1.89

1.1

5.44

7.10

nmol/l

0.30

241

Nonalcoholic fatty liver disease

275

1.53

1.89

1.0

1.1

6.28

4.66

nmol/l

0.09

Ulcerative colitis, NAS

373

1.45

1.88

1.1

2.53

6.02

nmol/l

—

Other diseases of the digestive system

109

844

1.29

1.87

1.1

4.64

8.47

nmol/l

0.75

169

Substance use, excluding alcohol

550

1.37

1.87

1.1

0.61

5.98

nmol/l

2.74

100

COPD (mode)

520

1.34

1.86

1.0

1.1

7.46

10.31

nmol/l

0.21

100

Adjustment and management of implanted device

407

1.43

1.86

1.0

1.1

3.47

7.02

nmol/l

0.80

Other disorders of veins

157

1251

1.24

1.85

1.1

17.56

5.94

nmol/l

0.44

240

Anterior Iridocyclitis

551

1.36

1.85

1.1

13.38

9.75

nmol/l

—

112

Non-follicular lymphoma

229

1.58

1.84

1.0

1.1

0.13

10.43

nmol/l

—

Other inflammatory liver diseases

175

1.66

1.82

1.2

1.1

9.90

6.56

nmol/l

—

Abnormal results of function studies

230

1.57

1.81

1.1

12.53

6.16

nmol/l

—

Disorders of optic nerve and visual pathways

254

1.54

1.81

1.1

1.74

5.15

nmol/l

—

Diseases of middle ear and mastoid

218

1490

1.20

1.81

1.1

5.02

5.87

nmol/l

0.12

265

Protozoal diseases

1.97

1.80

1.0

1.1

—

2.02

—

Seborrhoeic keratosis

683

1.32

1.80

1.1

3.58

9.46

nmol/l

1.02

132

Other noninflammatory disorders of vagina

168

1.67

1.80

1.1

0.10

9.95

nmol/l

—

Disorders of tooth development and eruption

325

1.43

1.80

1.1

2.32

10.28

nmol/l

—

Diabetes mellitus

402

2032

1.14

1.80

1.1

4.66

5.65

nmol/l

0.22

374

Cervical polyps

223

1.57

1.78

1.1

0.09

9.86

nmol/l

—

Nontoxic goitre/thyroid nodule

105

817

1.29

1.76

1.1

2.40

8.79

nmol/l

1.79

155

Fracture of lumbar spine and pelvis

564

1.35

1.74

1.1

1.59

10.80

nmol/l

2.36

124

Papulosquamous disorders

144

1165

1.24

1.74

1.1

8.24

7.07

nmol/l

0.10

225

severe traumatic brain injury, does not include concussion

540

1.35

1.74

1.0

1.1

9.65

9.99

nmol/l

0.02

109

Lichen ruber planus, wide definition including periferal and oral lichen planus

635

1.33

1.74

1.1

4.26

9.57

nmol/l

0.79

122

Acute renal failure

549

1.35

1.73

1.1

1.33

11.11

nmol/l

2.33

112

Sulfonylureas

686

0.73

1.73

1.0

1.1

2.61

9.17

nmol/l

1.49

144

Other disorders of skin and subcutaneous tissue, not elsewhere classified

355

1.44

1.73

1.0

1.1

2.38

13.25

nmol/l

—

Otitis externa

627

1.33

1.73

1.1

6.06

8.90

nmol/l

0.19

123

Diabetic maculopathy

250

1.51

1.72

1.0

1.1

0.55

5.57

nmol/l

—

Leisure time condition

482

1.37

1.71

1.1

2.35

10.88

nmol/l

1.36

Sequelae of injuries of lower limb

234

1.54

1.70

1.1

8.36

3.18

nmol/l

—

Presbycusis

303

1.47

1.70

1.1

2.12

14.84

nmol/l

—

216

1583

1.19

1.70

1.1

1.90

6.77

nmol/l

2.51

294

Poisoning by medicine, drug-induced

0.00

1.69

0.0

1.1

—

0.10

—

Malignant neoplasm of other and unspecified female genital organs

0.00

1.69

0.0

1.1

—

15.54

—

Inguinal hernia

202

1122

1.20

1.68

1.1

4.69

7.76

nmol/l

0.61

212

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

2.52

1.67

1.1

2.05

6.60

nmol/l

—

Pregnancy, childbirth and the puerperium

104

420

1.29

1.66

1.1

12.24

6.19

nmol/l

0.45

Optic neuritis

119

1.77

1.66

1.1

2.37

0.54

nmol/l

—

Unspecified privation

276

1.49

1.66

1.1

3.03

8.13

nmol/l

0.78

Persons with potential health hazards related to communicable diseases

139

1117

1.23

1.66

1.1

6.67

5.63

nmol/l

0.07

203

Other diseases of stomach and duodenum

165

1.64

1.0

1.1

10.19

4.64

nmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

633

1.31

1.63

1.1

7.61

7.20

nmol/l

0.03

123

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

253

1.51

1.62

1.1

0.08

7.77

nmol/l

—

Type 2 diabetes

386

1967

1.14

1.62

1.1

4.87

5.77

nmol/l

0.19

363

Open wound of forearm

237

1.52

1.62

1.1

2.53

7.25

nmol/l

—

Gastric ulcer

420

1.38

1.60

1.1

4.89

8.64

nmol/l

0.28

Non-allergic asthma

198

1.57

1.59

1.1

0.59

6.10

nmol/l

—

Car occupant injured in other and unspecified transport accidents

515

1.34

1.58

1.1

3.90

6.53

nmol/l

0.52

Complications predominantly related to the puerperium

777

1.28

1.58

1.1

0.28

7.00

nmol/l

1.76

134

Superficial injury of thorax

379

1.40

1.58

1.0

1.1

2.49

8.33

nmol/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

172

1241

1.20

1.58

1.1

9.21

5.37

nmol/l

0.35

213

Other fall from one level to another

593

1.32

1.57

1.1

3.35

7.55

nmol/l

0.81

119

Effects of foreign body entering through natural orifice

646

1.30

1.57

1.1

2.10

10.09

nmol/l

2.10

129

Contact with machinery

247

1.50

1.57

1.0

1.1

1.05

6.45

nmol/l

—

5-aminosalicylic acid

516

1.34

1.56

1.1

0.76

8.28

nmol/l

1.11

Scleritis

2.30

1.56

1.3

1.1

—

0.33

—

Superficial injury of shoulder and upper arm

305

1.45

1.55

1.1

3.95

9.40

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

1.89

1.55

1.1

1.2

—

3.86

nmol/l

—

Nonsuppurative otitis media, including avohilmo

117

811

1.25

1.54

1.1

3.94

7.68

nmol/l

0.66

147

Presence of other devices

603

1.31

1.54

1.1

0.71

9.65

nmol/l

2.59

125

Glaucoma, exfoliation

224

1.52

1.53

1.0

1.1

1.64

13.88

nmol/l

—

Disorders of continuity of bone

265

1.48

1.53

1.1

1.71

6.42

nmol/l

—

Rosacea

365

1.40

1.52

1.1

6.56

13.07

nmol/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

450

1.36

1.52

1.2

1.1

0.25

4.17

nmol/l

2.31

Ventral hernia

632

1.30

1.52

1.1

1.01

10.07

nmol/l

2.27

117

Hypertrophy of breast in women and men

571

1.32

1.52

1.1

2.41

8.93

nmol/l

0.98

101

Struck by thrown, projected or falling objec

138

1.67

1.51

1.2

1.1

2.91

2.60

nmol/l

—

Heart failure and hypertrophic cardiomyopathy

0.00

1.51

0.0

1.2

—

0.14

—

Pacemaker

114

850

1.25

1.51

1.1

7.67

8.85

nmol/l

0.09

171

Anogenital herpesviral [herpes simplex] infection, including avohilmo

307

1.44

1.51

1.1

2.29

4.21

nmol/l

—

Other and/or unspecified nontoxic goitre

201

1.55

1.51

1.1

3.56

14.92

nmol/l

—

Diabetes, varying definitions

396

2037

1.13

1.50

1.1

4.80

5.62

nmol/l

0.18

376

Follow-up examination after treatment for malignant neoplasms

154

1.63

1.49

1.0

1.1

0.08

16.70

nmol/l

—

Benign leiomyoma with endometriosis

426

1.36

1.49

1.1

16.78

9.89

nmol/l

0.36

Other bullous disorders

1.96

1.49

1.0

1.1

—

1.85

—

Other diseases of blood and blood-forming organs, wide

591

1.31

1.48

1.1

6.37

10.00

nmol/l

0.38

122

Stenosis and insufficiency of lacrimal passages

194

1.55

1.48

1.3

1.1

7.65

14.02

nmol/l

—

Fall on and from stairs and steps

741

1.27

1.47

1.0

1.1

6.08

8.39

nmol/l

0.22

143

202

1535

1.18

1.46

1.1

1.95

6.91

nmol/l

2.50

288

Endometriosis diagnosis and infertility diagnosis occurring together

301

1.43

1.46

1.1

1.48

3.58

nmol/l

—

GI-bleeding

105

840

1.25

1.45

1.0

1.1

4.47

8.50

nmol/l

0.82

169

Foreign body entering into or through eye or natural orifice

203

1.53

1.45

1.2

1.1

2.39

4.33

nmol/l

0.50

Palmar fascial fibromatosis [Dupuytren]

318

1.42

1.45

1.0

1.1

1.15

13.55

nmol/l

—

Hypertrophic scar

140

1.65

1.45

1.0

1.1

4.15

7.05

nmol/l

—

Presence of cardiac and vascular implants and grafts

139

840

1.22

1.45

1.0

1.1

6.27

8.47

nmol/l

0.17

176

Burns and corrosions

352

1.39

1.45

1.2

1.1

0.15

5.29

nmol/l

—

Disorders of other and unspecified cranial nerves

3.18

1.44

1.0

1.1

—

Congenital malformations of the nervous system

1.98

1.44

1.1

1.2

—

0.43

—

Fracture at wrist and hand level

120

973

1.23

1.44

1.1

1.91

8.05

nmol/l

2.06

173

All chronic kidney diseases

190

1284

1.18

1.43

1.1

2.92

8.18

nmol/l

2.15

229

Polyp of the female genital tract

432

1.27

1.43

1.1

4.46

5.46

nmol/l

0.09

Mental and behavioural disorders due to alcohol

178

1432

1.18

1.43

1.1

0.68

6.64

nmol/l

4.18

266

Other disorders of the genitourinary system

336

1.40

1.43

1.1

30.74

7.38

nmol/l

0.44

Gastroduodenal ulcer

628

1.29

1.42

1.1

7.03

6.66

nmol/l

0.02

125

Other septicaemia

126

973

1.22

1.41

1.1

8.17

8.27

nmol/l

0.01

193

Peripheral artery operations in Hilmo

289

0.59

1.40

1.0

1.1

0.14

10.33

nmol/l

—

Infections with a predominantly sexual mode of transmission, including avohilmo

149

1135

1.20

1.40

1.1

1.25

6.35

nmol/l

1.82

201

Alzheimer disease

603

0.76

1.40

1.0

1.1

1.90

10.51

nmol/l

—

133

2.19

1.40

1.0

1.1

—

0.48

—

Lichen planus

346

1.39

1.40

1.1

1.29

12.24

nmol/l

—

L04AC Interleukin inhibitors

173

1.57

1.40

1.0

1.1

11.98

1.60

nmol/l

—

Other diseases of intestine

380

1.37

1.40

1.1

3.32

6.35

nmol/l

0.94

Renal failure

154

1097

1.20

1.38

1.1

1.75

8.34

nmol/l

3.14

212

Hypertrophic disorders of skin

150

1.61

1.38

1.0

1.2

4.15

6.39

nmol/l

—

Pruritus

305

1.41

1.37

1.0

1.1

1.36

15.29

nmol/l

—

Other vitreous opacities

104

1.74

1.37

1.0

1.1

2.80

3.24

nmol/l

—

Infections of the skin and subcutaneous tissue

215

1824

1.16

1.36

1.1

1.37

6.35

nmol/l

3.08

343

Other coagulation defects

207

1.50

1.35

1.1

0.20

9.57

nmol/l

—

Chronic myeloproliferative disease

0.00

1.35

0.0

1.1

—

1.20

—

Uterine polyps

414

1.27

1.34

1.1

0.84

5.82

nmol/l

1.89

Benign lipomatous neoplasm

104

841

1.24

1.34

1.1

2.60

8.48

nmol/l

1.33

162

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

1.34

0.0

1.1

—

4.62

—

Malignant neoplasm of other and unspecified parts of biliary tract

0.00

1.33

0.0

1.1

—

2.19

—

Explicit Sepsis

142

1079

1.20

1.32

1.1

7.71

7.64

nmol/l

0.01

202

Haemorrhage in early pregnancy

105

827

1.23

1.32

1.1

0.57

7.04

nmol/l

1.63

137

Discitis, unspecified

0.00

1.31

0.0

1.1

—

10.44

—

Pericarditis

1.82

1.31

1.0

1.1

7.91

7.81

nmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

168

1.55

1.31

1.0

1.1

1.64

17.09

nmol/l

—

Other acquired deformities of musculoskeletal system and connective tissue

121

1.66

1.31

1.2

1.1

3.60

2.93

nmol/l

—

Other abnormal findings of blood chemistry

121

1.66

1.30

1.2

1.1

—

2.44

nmol/l

—

Postzoster neuralgia

2.11

1.30

1.1

—

2.66

—

Sequelae of other external causes

145

1.59

1.29

1.1

4.41

3.09

nmol/l

—

Hypertrophy of breast

499

1.31

1.28

1.1

2.20

10.13

nmol/l

0.96

Agoraphobia

1.89

1.28

1.0

1.1

—

6.16

—

Idiopathic gout

218

1.47

1.28

1.1

5.69

7.33

nmol/l

0.21

Anomalies of dental arch relationship, including avohilmo

516

1.28

1.25

1.2

1.1

2.16

5.70

nmol/l

0.99

Any event in cancer register

352

1836

1.12

1.25

1.1

9.09

4.87

nmol/l

0.35

332

Vitamin B12 deficiency anaemia

244

1.44

1.25

1.1

1.48

7.63

nmol/l

—

Use of donepezil

460

0.70

1.25

1.0

1.1

3.15

12.16

nmol/l

—

102

133

999

1.20

1.25

1.1

19.23

6.51

nmol/l

0.52

197

Septicaemia

140

1071

1.19

1.25

1.1

7.72

7.83

nmol/l

0.01

211

Primary coxarthrosis, bilateral

759

1.24

1.25

1.1

4.90

8.14

nmol/l

0.57

154

Contact with and exposure to communicable diseases

109

890

1.22

1.24

1.1

8.28

3.14

nmol/l

0.35

167

Pneumoconiosis due to asbestos and other mineral fibres

2.41

1.24

1.3

1.2

—

8.82

—

Other disorders of cornea

253

1.43

1.23

1.1

3.82

11.99

nmol/l

—

Other infectious diseases

187

1.50

1.23

1.1

4.46

3.79

nmol/l

—

Motorcycle rider injured in other and unspecified transport accidents

139

1.59

1.23

1.1

3.78

1.30

nmol/l

—

Acute pancreatitis

494

1.30

1.23

1.1

7.66

10.83

nmol/l

0.23

Heart failure and bmi 25plus

110

600

1.22

1.23

1.1

10.33

7.50

nmol/l

0.24

128

Systemic sclerosis (FG)

1.98

1.22

1.2

—

0.79

—

Type 1 diabetes

707

1.24

1.21

1.1

6.86

8.21

nmol/l

0.10

141

Other congenital malformations of skin, including avohilmo

221

1.45

1.21

1.2

1.1

0.09

6.14

nmol/l

—

Thoracic aortic aneurysm

365

1.35

1.20

1.0

1.1

4.24

9.11

nmol/l

—

Crohn disease

348

1.35

1.20

1.0

1.1

11.15

6.31

nmol/l

—

Other specified/unspecified hearing loss

213

1.46

1.20

1.1

7.44

10.47

nmol/l

—

Other specified/unspecified bacterial intestinal infections

164

1.53

1.20

1.1

0.80

4.24

nmol/l

—

Fracture of neck

156

1.54

1.20

1.0

1.1

6.78

6.69

nmol/l

—

Deep bite

260

1.39

1.19

1.2

1.1

1.65

3.02

nmol/l

—

malignant neoplasm of male genital organs, including Hilmo

481

0.77

1.19

1.0

1.1

6.31

6.47

nmol/l

0.02

Cutaneous abscess, furuncle and carbuncle

737

1.24

1.19

1.2

1.1

0.43

9.66

nmol/l

3.34

146

Ectopic pregnancy

497

1.29

1.18

1.1

1.09

12.96

nmol/l

1.66

Heart failure,strict

172

1028

1.17

1.18

1.1

7.69

7.77

nmol/l

0.01

198

Abnormal spermatozoa

298

0.64

1.17

1.1

—

7.64

—

Oral lichen planus, including avohilmo , including avohilmo

198

1.47

1.16

1.1

4.67

7.03

nmol/l

—

Injuries involving multiple body regions

102

1.67

1.16

1.1

1.92

1.14

nmol/l

—

Other septicaemia, including avohilmo

126

992

1.19

1.15

1.1

8.17

8.27

nmol/l

0.01

193

Pre-eclampsia or poor fetal growth

112

926

1.21

1.15

1.1

0.17

6.66

nmol/l

1.90

154

Malignant melanoma of skin

308

1.37

1.15

1.2

1.0

3.20

9.70

nmol/l

—

Convalescence

126

1.59

1.14

1.1

1.2

1.86

4.58

nmol/l

—

Injury of unspecified body region

199

1.46

1.14

1.1

7.40

7.33

nmol/l

—

Other congenital malformations

224

1.43

1.13

1.2

1.1

1.58

2.68

nmol/l

—

Leiomyoma of uterus

230

1132

1.14

1.12

1.1

2.32

6.80

nmol/l

1.00

189

Pre-eclampsia or eclampsia

618

1.25

1.11

1.1

0.19

7.11

nmol/l

1.28

101

Glucagon-like peptide-1 (GLP-1) analogues

112

935

1.20

1.11

1.1

2.90

7.86

nmol/l

1.34

174

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

112

935

1.20

1.11

1.1

2.90

7.86

nmol/l

1.34

174

Malignant melanoma of skin, including Hilmo

371

1.32

1.10

1.2

1.0

3.06

8.75

nmol/l

1.64

Contraceptive management

142

843

1.18

1.10

1.1

0.69

4.45

nmol/l

2.28

140

Psoriasis vulgaris

512

1.27

1.10

1.1

9.60

10.98

nmol/l

0.07

Myocardial infarction, without ST-elevation

123

934

1.19

1.10

1.1

6.98

8.53

nmol/l

0.15

196

Other respiratory diseases principally affecting the interstitium

446

0.72

1.09

1.0

1.1

5.18

12.06

nmol/l

—

Female infertility

449

1.23

1.09

1.0

1.1

1.02

6.11

nmol/l

1.70

Benign neoplasm of bone and articular cartilage

218

1.43

1.09

1.1

0.09

6.87

nmol/l

—

Other disorders of pigmentation

120

1.59

1.08

1.1

1.2

0.11

6.57

nmol/l

—

Explicit Sepsis, including avohilmo

142

1098

1.17

1.08

1.1

7.72

7.46

nmol/l

0.03

207

Schizophrenia, schizotypal and delusional disorders

105

874

1.20

1.08

1.1

2.77

7.52

nmol/l

1.06

162

Acute suppurative otitis media

704

1.22

1.07

1.1

0.87

4.57

nmol/l

1.79

126

Other contact dermatitis

202

1.44

1.07

1.3

1.1

0.40

6.66

nmol/l

—

Myocardial infarction

152

910

1.17

1.07

1.1

6.12

7.48

nmol/l

0.16

181

Combinations of oral blood glucose lowering drugs

803

0.80

1.05

1.1

8.88

7.83

nmol/l

0.06

157

Early lumbar disc prolapse operation

297

1.35

1.04

1.1

0.10

3.90

nmol/l

—

Acute appendicitis, no complications

203

1776

1.14

1.04

1.1

1.44

6.28

nmol/l

2.77

318

Nontoxic single thyroid nodule

187

1.45

1.03

1.1

0.16

18.82

nmol/l

—

DVT of lower extremities

490

1.27

1.03

1.1

7.52

8.05

nmol/l

0.04

101

Other infectious diseases, including avohilmo

229

1.40

1.03

1.1

4.46

4.43

nmol/l

—

Gout, unspecified

508

1.26

1.03

1.1

3.45

7.34

nmol/l

0.92

113

Other and unspecified coagulation defects

138

1.53

1.03

1.1

0.09

1.65

nmol/l

—

Lichen planus, including avohilmo

527

1.25

1.01

1.1

3.58

11.21

nmol/l

—

Pneumocystosis, including avohilmo

1.90

1.01

1.0

1.2

—

2.23

—

Pneumocystosis

1.90

1.01

1.0

1.2

—

2.23

—

Injury of muscle and tendon at shoulder and upper arm level

119

1009

1.18

1.01

1.1

3.82

7.42

nmol/l

0.68

195

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

581

1.24

1.01

1.1

0.11

3.19

nmol/l

1.71

110

Alzheimer disease, including avohilmo

677

0.82

1.01

1.1

4.97

9.30

nmol/l

0.46

147

Malignant neoplasm of prostate, including Hilmo

454

0.79

1.00

1.0

1.1

6.31

6.73

nmol/l

0.05

Occupational exposure to risk-factors

1.66

1.00

1.0

1.1

—

4.87

nmol/l

—

Any dementia, excluding more controls

105

602

1.20

1.00

1.0

1.1

1.68

11.02

nmol/l

2.48

124

Peritonsillar abscess

519

1.25

1.00

1.1

3.38

5.63

nmol/l

0.33

Pregnancy hypertension

151

1166

1.16

1.00

1.1

8.23

5.71

nmol/l

0.19

198

Malignant neoplasm of prostate

448

0.79

0.99

1.1

6.30

6.73

nmol/l

0.05

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

172

1.46

0.99

1.0

1.1

3.28

12.82

nmol/l

—

Hypertensive heart and/or renal disease

463

1.23

0.99

1.1

8.87

9.19

nmol/l

0.02

Insulin, intermediate and long-acting

185

1568

1.14

0.98

1.1

5.84

6.70

nmol/l

0.11

291

Delivery, wide proxy

110

489

1.19

0.98

1.1

12.62

5.26

nmol/l

0.53

Other infective otitis externa

156

1.48

0.98

1.0

1.1

0.66

3.12

nmol/l

—

Maternal care for known or suspected fetal abnormality and damage

372

1.28

0.98

1.1

0.10

2.40

nmol/l

1.03

Injuries to the elbow and forearm

258

1981

1.12

0.98

1.1

9.61

5.31

nmol/l

0.24

364

Bronchiectasis

181

1.44

0.98

1.1

12.09

8.02

nmol/l

—

Hypertensive Heart Disease

434

1.24

0.98

1.1

7.61

9.31

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

357

2052

1.10

0.98

1.1

8.90

5.21

nmol/l

0.31

374

Later onset COPD, excluding more controls

321

1.28

0.97

1.0

1.1

6.32

14.82

nmol/l

0.63

Other follicular disorders

198

1.42

0.97

1.1

0.11

5.96

nmol/l

—

Viral infections of the central nervous system, including avohilmo

198

1.42

0.97

1.0

1.1

0.08

5.11

nmol/l

—

Salpingitis and oophoritis

486

1.26

0.97

1.1

1.82

11.02

nmol/l

—

Morphin

1.86

0.97

1.0

1.1

—

6.94

—

Other diseases of pericardium

100

1.61

0.96

1.1

1.2

9.70

10.01

nmol/l

—

Diseases of appendix

272

2188

1.11

0.96

1.1

2.23

5.59

nmol/l

2.01

401

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

411

1.28

0.96

1.1

5.65

7.32

nmol/l

—

Insulin, fast-acting

122

1042

1.17

0.96

1.1

7.25

7.72

nmol/l

0.04

196

Hypoglycaemia, other or unspecified

157

1.47

0.96

1.1

0.10

5.31

nmol/l

—

Acquired stenosis of external ear canal

0.00

0.95

0.0

1.2

—

1.94

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

0.00

0.95

0.0

1.1

—

3.28

—

Frostbite

0.00

0.95

0.0

1.1

—

0.08

—

Superficial injuries involving multiple body regions

1.70

0.95

1.1

1.92

1.18

nmol/l

—

Dermatitis herpetiformis

1.77

0.95

1.0

1.1

—

0.11

—

Schizophrenia or delusion

103

869

1.19

0.94

1.1

2.77

7.57

nmol/l

1.07

161

Dermatitis due to ingested food

1.84

0.94

1.1

1.2

—

0.21

—

Other keratitis

294

1.33

0.94

1.0

1.1

2.56

6.37

nmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

122

946

1.17

0.93

1.1

21.62

6.83

nmol/l

0.54

187

Peripheral arterial reconstruction

304

0.69

0.92

1.0

3.33

0.11

nmol/l

—

Diseases of spleen

1.83

0.92

1.1

—

1.66

—

Colorectal adenocarcinoma

515

0.77

0.92

1.1

1.0

6.83

7.60

nmol/l

0.05

107

Malignant melanoma, including Hilmo

454

1.26

0.92

1.2

1.0

3.71

7.71

nmol/l

1.12

Insulin, fast-acting or short human

123

1056

1.17

0.92

1.1

7.25

7.68

nmol/l

0.04

197

Malignant neoplasm of anus and anal canal, including Hilmo

2.16

0.92

1.0

1.1

—

3.27

—

Dermatophytosis

348

1.30

0.91

1.2

1.1

12.26

9.19

nmol/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

244

1.36

0.90

1.1

20.70

16.78

nmol/l

—

Nonsuppurative otitis media

550

1.22

0.90

1.1

3.58

9.86

nmol/l

0.83

105

Myocardial infarction, strict

137

838

1.16

0.90

1.1

6.12

7.74

nmol/l

0.20

174

Invasive ventilation

176

1.42

0.90

1.1

1.19

4.24

nmol/l

—

Systemic sclerosis

1.75

0.90

1.2

—

1.17

—

malignant neoplasm of male genital organs

469

0.81

0.90

1.0

1.1

6.30

6.47

nmol/l

0.02

Basal cell carcinoma

155

922

1.15

0.90

1.1

1.0

2.71

6.64

nmol/l

1.62

169

Chronic periodontitis, complicated

197

1707

1.13

0.89

1.1

3.96

7.05

nmol/l

0.98

317

Later onset COPD

560

0.80

0.88

1.0

1.1

6.32

10.52

nmol/l

0.39

119

Appendicitis, broad definition

268

2175

1.11

0.88

1.1

2.23

5.63

nmol/l

2.04

398

Foreign body in respiratory tract

127

1.50

0.88

1.1

1.92

3.51

nmol/l

—

Seropositive rheumatoid arthritis, strict definition

416

0.74

0.88

1.2

1.1

0.42

13.14

nmol/l

—

Fracture of foot, except ankle

683

1.20

0.88

1.0

1.1

2.20

8.71

nmol/l

1.20

137

Habitual aborter

1.87

0.87

1.0

1.1

—

9.92

—

Malignant melanoma

404

1.26

0.87

1.2

1.0

3.87

8.22

nmol/l

1.10

Actinic keratosis

118

923

1.16

0.87

1.1

21.62

6.97

nmol/l

0.53

183

246

1.34

0.87

1.1

1.84

4.63

nmol/l

0.41

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

662

0.80

0.86

1.1

1.0

0.15

6.72

nmol/l

—

131

Injury of muscle and tendon at hip and thigh level

264

1.33

0.85

1.1

0.64

3.17

nmol/l

—

Basal cell carcinoma, including Hilmo

159

945

1.14

0.85

1.1

1.0

3.18

6.46

nmol/l

1.23

177

Other and unspecified nonorganic psychotic disorders

531

1.23

0.85

1.2

1.1

2.55

5.53

nmol/l

0.66

100

Maternal care for known or suspected abnormality of pelvic organs

498

1.19

0.85

1.1

9.21

3.64

nmol/l

0.32

Dislocation of lens

1.94

0.84

1.0

1.2

—

4.19

—

Corneal ulcer

505

1.23

0.84

1.1

3.09

10.00

nmol/l

1.05

Bacterial, viral and other infectious agents, including avohilmo

239

1.34

0.84

1.1

0.94

5.37

nmol/l

—

Cardiomyopathy, other and unspecified

179

1.40

0.84

1.0

1.1

0.09

10.27

nmol/l

—

Benign neoplasm of mouth and pharynx

274

1.32

0.83

1.0

1.1

0.17

8.87

nmol/l

—

Acute pancreatitis (for exclusion)

524

1.22

0.83

1.1

7.66

10.97

nmol/l

0.25

107

Sulfasalazine

734

1.19

0.83

1.1

6.90

6.86

nmol/l

0.00

115

Abnormal findings on antenatal screening of mother

231

1.34

0.82

1.2

1.1

0.14

1.80

nmol/l

—

Foreign body on external eye

363

1.27

0.82

1.1

0.76

6.07

nmol/l

—

Urolithiasis

103

884

1.17

0.81

1.1

3.50

8.96

nmol/l

1.39

170

LSIL lesion of the cervix uteri

329

1.28

0.80

1.0

1.1

0.36

3.27

nmol/l

—

Alcohol use disorder, Swedish definition

183

1485

1.12

0.79

1.1

2.03

6.79

nmol/l

2.16

279

Disorder of lipoprotein metabolism, unspecified

294

1.29

0.79

1.1

5.10

13.17

nmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.79

0.0

1.2

—

0.08

—

Osteomyelitis

156

1.41

0.78

1.0

1.1

4.97

6.72

nmol/l

—

Peptic ulcer

0.00

0.78

0.0

1.1

—

2.22

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

0.78

0.0

1.2

—

0.08

—

Infections of breast associated with childbirth

1.54

0.78

1.3

1.1

0.40

7.11

nmol/l

—

Use of memantine

543

0.81

0.78

1.0

1.1

7.47

11.41

nmol/l

—

118

Use of other anti-dementia drugs

543

0.81

0.78

1.0

1.1

7.47

11.41

nmol/l

—

118

Alzheimer’s disease, strict definition

500

0.81

0.78

1.0

1.1

0.23

12.26

nmol/l

—

110

Pyogenic arthritis

131

1.45

0.78

1.2

1.1

5.03

16.70

nmol/l

—

Psoriasis

813

1.17

0.78

1.1

11.81

8.65

nmol/l

0.20

150

Atrial septal defect

0.52

0.78

1.0

1.1

—

1.32

nmol/l

—

Dementia, including avohilmo

143

857

1.14

0.78

1.0

1.1

4.47

9.37

nmol/l

1.02

171

Impacted cerumen

295

1.29

0.78

1.0

1.1

2.03

13.28

nmol/l

1.43

Gestational [pregnancy-induced] hypertension

793

1.17

0.78

1.1

17.72

5.78

nmol/l

0.55

133

Other blood glucose lowering drugs, excl. Insulins

384

1.25

0.78

1.1

0.66

11.57

nmol/l

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.78

0.0

1.1

—

0.12

—

L02BX Other hormone antagonists and related agents

123

0.57

0.78

1.0

1.1

—

10.40

—

Malignant neoplasm, wide definition

326

1743

1.09

0.77

1.1

9.78

5.15

nmol/l

0.36

308

Acquired absence of limb

0.00

0.76

0.0

1.0

—

2.67

—

Liquid cancers, including Hilmo

118

906

1.15

0.76

1.1

3.98

6.83

nmol/l

0.46

169

Other/unspecified reactive arthropathies

166

1.39

0.75

1.2

1.1

0.12

4.20

nmol/l

—

Vascular disorders of the intestines

149

1.41

0.75

1.0

1.1

15.06

6.44

nmol/l

—

Medicines for HER+ breast cancer

1027

0.86

0.75

1.1

1.02

7.48

nmol/l

2.39

187

Type 2 diabetes, definitions combined

355

1907

1.08

0.75

1.1

4.78

5.97

nmol/l

0.27

351

Diabetic retinopathy

100

533

1.16

0.74

1.1

0.50

6.60

nmol/l

3.74

Suggestive for eosinophilic asthma

227

1.32

0.74

1.1

7.43

8.86

nmol/l

—

Viral warts, including avohilmo

605

1.19

0.74

1.1

3.67

9.12

nmol/l

—

116

Hydrocele

227

1.32

0.74

1.1

1.18

6.50

nmol/l

—

Benign neoplasm: Ascending colon

360

1.25

0.74

1.1

1.10

12.84

nmol/l

—

Congenital malformations of heart and great arteries

306

1.27

0.73

1.1

5.09

7.03

nmol/l

—

Female infertility, cervical, vaginal, other or unspecified origin

438

1.18

0.73

1.0

1.1

1.02

6.34

nmol/l

1.68

IBD patients in KELA-register

634

1.18

0.73

1.1

1.46

8.68

nmol/l

1.57

118

FESS (DNB20)

352

1.25

0.72

1.1

4.40

9.03

nmol/l

0.73

Iron deficiency anaemia secondary to blood loss (chronic)

415

1.23

0.72

1.1

0.09

10.74

nmol/l

—

Other (seronegative) rheumatoid arthritis, wide

506

1.21

0.72

1.1

1.49

10.81

nmol/l

—

103

Other predominantly sexually transmitted diseases, not elsewhere classified

497

1.21

0.72

1.1

0.11

2.66

nmol/l

1.67

Diabetes medication

389

2110

1.08

0.72

1.1

4.99

5.52

nmol/l

0.11

387

Malignant neoplasm, including Hilmo

324

1740

1.08

0.72

1.1

9.96

5.15

nmol/l

0.36

308

Acute appendicitis

248

2103

1.09

0.72

1.1

2.15

5.78

nmol/l

2.11

385

Diabetes mellitus in pregnancy

116

643

1.15

0.72

1.2

1.1

10.14

2.64

nmol/l

0.59

102

Scissor bite

1.59

0.71

1.4

1.1

—

0.20

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

217

1529

1.10

0.71

1.1

0.35

6.75

nmol/l

4.63

285

Type 2 diabetes, strict (exclude DM1)

355

1913

1.08

0.71

1.1

4.78

5.93

nmol/l

0.26

353

Chronic pancreatitis

291

1.27

0.70

1.1

3.51

13.76

nmol/l

—

Loose body in joint

1.71

0.70

1.0

—

4.40

—

Biguanides

357

1999

1.08

0.69

1.1

5.93

5.64

nmol/l

0.05

370

Rheumatoid arthritis, including avohilmo

124

1095

1.13

0.69

1.1

5.17

7.48

nmol/l

0.27

213

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

441

1.21

0.69

1.1

5.65

7.19

nmol/l

—

Hyperfunction of pituitary gland

135

1.41

0.69

1.0

1.1

3.12

4.43

nmol/l

—

Schizoaffective disorder

204

1.33

0.68

1.1

3.92

6.25

nmol/l

—

Acute mastoiditis

1.86

0.68

1.2

1.1

—

0.38

—

Systemic sclerosis, icd10

1.60

0.68

1.2

1.1

—

1.04

—

Coagulation defects, purpura and other haemorrhagic conditions

519

1.20

0.68

1.0

1.1

1.66

11.21

nmol/l

1.81

101

Abnormal findings in secretions and smears from cervix uteri vagina vulva

182

1208

1.11

0.68

1.1

0.38

6.50

nmol/l

2.72

211

Antepartum haemorrhage, not elsewhere classified

222

1.31

0.68

1.0

1.1

4.80

3.77

nmol/l

—

Alcohol abuse, main dg

401

1.22

0.67

1.2

1.1

1.01

6.56

nmol/l

—

Cardiomyopathy

428

1.22

0.67

1.1

1.95

11.35

nmol/l

—

Other specified disorders of kidney and ureter

0.55

0.67

1.0

1.1

—

2.18

—

Hyperkalaemia

119

1.43

0.67

1.2

1.1

12.16

11.86

nmol/l

—

Childhood allergy (age < 16)

256

1.26

0.66

1.2

1.1

0.86

4.37

nmol/l

—

Prepatellar bursitis

1.49

0.66

1.4

1.1

9.18

7.23

nmol/l

—

Enterocolitis due to Clostridium difficile

258

1.28

0.66

1.1

0.27

9.05

nmol/l

—

Other benign neoplasm of uterus: Other parts/unspecified

0.53

0.66

1.0

1.1

—

11.87

—

Amputation

226

0.71

0.66

1.1

0.14

10.82

nmol/l

—

Routine general health check-up of defined subpopulation

1.79

0.66

1.0

1.1

—

0.11

—

Heart failure and coronary heart disease

124

768

1.13

0.65

1.1

8.51

8.46

nmol/l

0.00

154

Benign neoplasm: Other/unspecified site

1.60

0.65

1.0

1.1

—

1.90

—

Maternal care for known or suspected malpresentation of fetus

384

1.19

0.65

1.0

1.1

0.09

2.38

nmol/l

—

Suppurative and unspecified otitis media

121

950

1.13

0.64

1.1

4.98

6.66

nmol/l

0.17

174

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

172

1.34

0.63

1.1

1.24

3.44

nmol/l

—

Secondary uncertain malignant neoplasm

332

1.24

0.63

1.0

1.1

3.72

9.61

nmol/l

—

Perineal laceration during delivery

424

0.82

0.63

1.1

0.14

4.12

nmol/l

1.37

633

1.15

0.62

1.1

4.80

10.73

nmol/l

0.81

137

Other and unspecified bullous disorders

1.67

0.61

1.0

1.1

—

0.14

—

Colorectal cancer

606

0.84

0.61

1.1

6.49

6.81

nmol/l

0.03

120

1.67

0.61

1.0

1.1

—

0.34

—

Infections with a predominantly sexual mode of transmission

104

915

1.13

0.61

1.1

1.09

6.30

nmol/l

1.56

165

Sub-endpoint used in defining T1D endpoints

764

1.15

0.61

1.1

6.91

6.69

nmol/l

0.02

146

Labour and delivery complicated by fetal stress [distress]

503

0.85

0.61

1.1

1.61

5.34

nmol/l

—

Other disorders of glucose regulation and pancreatic internal secretion

209

1.29

0.60

1.1

0.10

5.32

nmol/l

—

Ethmoidectomy

362

1.22

0.60

1.1

4.40

8.87

nmol/l

0.71

Vitreous haemorrhage

245

1.27

0.59

1.1

0.35

9.59

nmol/l

—

Other abnormal products of conception

117

682

1.13

0.59

1.1

0.08

5.35

nmol/l

2.12

105

COPD, hospital admissions 1, only main diagnosis

780

0.87

0.59

1.0

1.1

5.10

8.88

nmol/l

0.55

156

Complications peculiar to reattachment and amputation

0.00

0.58

0.0

1.2

—

0.12

—

Retinal breaks without detachment

418

1.20

0.58

1.1

11.31

10.80

nmol/l

—

Retinal detachments and breaks

110

978

1.13

0.58

1.1

5.29

7.78

nmol/l

0.28

202

Benign neoplasm of breast

327

1.22

0.58

1.1

10.38

13.91

nmol/l

—

Male infertility

1.46

0.58

1.2

1.1

—

2.38

—

Dementia

131

803

1.12

0.57

1.0

1.1

3.90

9.59

nmol/l

1.22

162

Myocardial infarction, with ST-elevation

409

0.81

0.57

1.1

6.63

8.58

nmol/l

0.22

Pre-eclampsia

576

1.16

0.57

1.1

0.22

7.48

nmol/l

1.22

Benign neoplasm: Lip

1.49

0.57

1.1

—

2.37

—

Insulin, fast-acting (human)

355

1.21

0.57

1.0

1.1

0.09

5.54

nmol/l

—

Supervision of normal pregnancy

332

1.17

0.57

1.0

1.1

0.89

4.30

nmol/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

201

1674

1.09

0.57

1.1

5.42

6.50

nmol/l

0.16

312

Insulin medication

201

1531

1.09

0.56

1.1

5.42

5.93

nmol/l

0.07

290

Other interstitial pulmonary diseases

386

0.80

0.56

1.0

1.1

5.18

13.35

nmol/l

—

Medical abortion

226

1127

1.09

0.56

1.1

2.04

7.52

nmol/l

1.71

193

Injury of muscle and tendon at wrist and hand level

347

1.21

0.56

1.2

1.1

2.67

8.71

nmol/l

1.48

Alzheimer’s disease (Early onset)

0.56

1.0

1.1

—

5.55

—

Inflammatory bowel disease, strict (require KELA)

653

1.15

0.55

1.1

1.46

8.47

nmol/l

1.55

121

Type1 diabetes, definitions combined, early onset

159

0.69

0.55

1.0

1.1

—

5.07

—

Poor fetal growth

339

1.21

0.54

1.2

1.1

0.11

3.09

nmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

1.50

0.54

1.0

1.1

—

3.24

—

Prurigo nodularis

1.50

0.54

1.1

—

4.08

—

Desensitization to allergens

142

1.34

0.54

1.0

1.1

—

6.42

—

Other congenital malformations of the digestive system, including avohilmo

125

0.63

0.54

1.1

1.2

—

2.58

—

Diabetic nephropathy

357

0.80

0.54

1.1

0.86

6.21

nmol/l

—

Acute alcohol intoxication

664

1.15

0.54

1.1

1.05

6.73

nmol/l

4.14

134

Early onset COPD

580

1.16

0.53

1.0

1.1

8.63

9.54

nmol/l

0.06

121

Alzheimer’s disease (Late onset)

450

0.84

0.53

1.0

1.1

0.23

12.80

nmol/l

—

105

Acute alcohol intoxication, ICD10

525

1.16

0.53

1.1

1.10

6.47

nmol/l

3.20

Interstitial lung disease endpoints

382

0.81

0.52

1.0

1.1

5.18

13.35

nmol/l

—

Interstitial lung disease

382

0.81

0.52

1.0

1.1

5.18

13.35

nmol/l

—

Type 1 diabetes, wide definition, subgroup 1

581

1.15

0.52

1.1

10.61

5.81

nmol/l

0.28

114

Lung cancer and mesothelioma

333

0.81

0.51

1.1

2.38

13.10

nmol/l

—

Respiratory disorders in diseases classified elsewhere

1.51

0.51

1.2

1.1

—

3.31

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

147

783

1.10

0.51

1.1

1.90

7.19

nmol/l

0.95

139

Otitis media, unspecified

256

1.22

0.50

1.1

12.57

3.14

nmol/l

—

Redundant prepuce, phimosis and paraphimosis

447

1.17

0.49

1.1

1.32

4.84

nmol/l

—

Lesion of plantar nerve

136

1.33

0.49

1.0

1.1

—

22.07

nmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

743

0.89

0.49

1.1

1.29

6.80

nmol/l

—

134

L02BA Anti-estrogens

465

0.84

0.49

1.1

1.08

10.13

nmol/l

—

Crowding of teeth, including avohilmo

186

1.25

0.48

1.1

5.78

2.97

nmol/l

—

Other congenital malformations of the digestive system

106

0.65

0.48

1.0

1.2

—

2.90

—

468

1.16

0.48

1.1

9.31

11.93

nmol/l

—

104

Cardiodefibrillation

104

933

1.11

0.48

1.0

1.1

6.85

7.91

nmol/l

0.08

195

Explicit bacterial Sepsis

226

1.24

0.47

1.1

5.36

10.33

nmol/l

—

Perichondritis of external ear

1.49

0.47

1.1

—

2.66

—

Malignant neoplasm of breast, HER-positive

742

0.89

0.47

1.1

1.29

6.85

nmol/l

—

133

Colon adenocarcinoma, helper endpoint

311

0.80

0.47

1.1

8.58

14.52

nmol/l

—

Postpartum haemorrhage due to retained placenta

336

1.19

0.47

1.1

0.22

4.43

nmol/l

—

Benign neoplasm: Caecum

281

1.21

0.47

1.2

1.1

2.03

15.93

nmol/l

1.51

COPD

130

961

1.10

0.47

1.0

1.1

6.91

7.14

nmol/l

0.02

186

ILD, hospital admissions

376

0.82

0.47

1.0

1.1

5.18

13.52

nmol/l

—

Melanocytic naevi, other sites/unspecified

236

1.23

0.46

1.2

1.1

—

7.93

nmol/l

—

Infectious mononucleosis, including avohilmo

209

1.25

0.46

1.0

1.1

1.84

4.74

nmol/l

—

Infectious mononucleosis

209

1.25

0.46

1.0

1.1

1.84

4.74

nmol/l

—

Preterm labour and delivery

768

1.12

0.46

1.1

3.88

9.42

nmol/l

0.61

122

Acute appendicitis, with complications

526

0.85

0.46

1.1

4.85

11.34

nmol/l

—

102

Molar incisor enamel hypoplasia

0.60

0.45

1.0

1.1

—

0.19

—

Burn and corrosion of trunk

0.59

0.45

1.2

1.1

—

3.51

—

Calculus of kidney and ureter

826

1.11

0.45

1.1

2.97

8.56

nmol/l

1.32

159

Degenerative macular diseases

283

1.20

0.44

1.1

0.10

13.06

nmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

695

1.12

0.44

1.0

1.1

8.04

8.97

nmol/l

0.06

153

Operations 2 for CAVS

695

1.12

0.44

1.0

1.1

8.04

8.97

nmol/l

0.06

153

Ulcer of lower limb, not elsewhere classified

357

1.18

0.44

1.0

1.1

0.63

13.92

nmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

350

1915

1.06

0.44

1.1

4.79

5.92

nmol/l

0.25

354

Prolonged pregnancy

365

0.84

0.44

1.1

0.70

2.36

nmol/l

—

Use of glatiramer acetate

1.38

0.44

1.1

—

0.31

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.38

0.44

1.1

—

0.30

—

Other or ill-defined heart diseases

121

1.32

0.44

1.1

0.56

6.03

nmol/l

—

Calcific aortic valvular stenosis, operated

696

1.12

0.44

1.0

1.1

8.04

8.97

nmol/l

0.06

153

Calcific aortic valvular stenosis

696

1.12

0.44

1.0

1.1

8.04

8.97

nmol/l

0.06

153

Other disorders of white blood cells

139

1.30

0.43

1.1

0.36

3.65

nmol/l

—

Other assisted single delivery

1.62

0.43

1.0

—

8.80

—

All-cause Heart Failure

179

1155

1.08

0.43

1.1

7.53

7.17

nmol/l

0.04

223

Calcific aortic valvular stenosis, including rheumatic fever

697

1.12

0.42

1.0

1.1

8.04

8.97

nmol/l

0.06

153

D07AA Corticosteroids, weak (group I)

414

1.16

0.42

1.1

0.12

5.48

nmol/l

—

Colon adenocarcinoma

306

0.82

0.42

1.1

1.0

8.58

10.28

nmol/l

—

Malignant neoplasm of corpus uteri, including Hilmo

218

0.78

0.42

1.1

1.0

0.09

10.00

nmol/l

—

Myocardial infarction, unclassifiable

437

0.86

0.42

1.0

1.1

6.34

11.65

nmol/l

0.45

conjunctival degenerations and deposits

1.38

0.41

1.1

—

0.10

—

Non-seminoma of testis, including Hilmo

0.00

0.41

0.0

1.1

—

2.63

—

Duodenal ulcer

250

0.80

0.41

1.1

12.16

5.18

nmol/l

—

Fracture of lower leg, including ankle

179

1638

1.07

0.40

1.1

3.32

6.40

nmol/l

0.83

302

Premenstrual syndrome

1.47

0.40

1.2

1.1

—

10.80

—

Cholecystitis

333

1.17

0.40

1.1

0.13

13.22

nmol/l

—

Generalized epilepsy

104

0.67

0.39

1.1

—

1.31

—

Somnolence

1.43

0.39

1.0

1.1

—

0.15

—

Myeloproliferative diseases

214

1.22

0.39

1.2

1.1

7.49

10.14

nmol/l

—

Other specified and unspecified disorders of choroid

0.00

0.39

0.0

1.1

—

Other (not insulin) diabetes medications

358

2000

1.05

0.39

1.1

5.49

5.73

nmol/l

0.04

370

Varicose veins

200

1415

1.07

0.39

1.1

2.97

6.45

nmol/l

1.95

269

L02BG Aromatase inhibitors

854

0.90

0.39

1.1

1.18

8.01

nmol/l

2.12

155

Retinal detachment with retinal break

313

0.83

0.38

1.0

1.1

1.69

12.94

nmol/l

—

Gestational diabetes (for exclusion)

130

824

1.09

0.38

1.1

7.83

2.23

nmol/l

0.57

132

Tubulo-interstitial nephritis, not specified as acute or chronic

160

1.25

0.38

1.1

8.14

4.64

nmol/l

—

Explicit bacterial Sepsis, including avohilmo

233

1.20

0.38

1.1

5.36

10.53

nmol/l

—

Arteriovenous malformation of cerebral vessels

1.39

0.38

1.0

1.1

—

0.08

—

Adalimumab

270

1.19

0.38

1.1

0.09

2.79

nmol/l

—

Solid cancers, including Hilmo

310

1714

1.05

0.38

1.1

9.78

5.24

nmol/l

0.35

302

Ill-defined and unknown causes of mortality

225

0.80

0.37

1.1

8.40

7.18

nmol/l

—

Gout, strict definition

448

1.14

0.37

1.1

4.02

7.98

nmol/l

1.00

101

Type 1 diabetes, wide definition

608

1.12

0.37

1.1

10.61

6.03

nmol/l

0.26

120

Hypoparathyroidism

1.33

0.37

1.1

1.2

0.23

4.28

nmol/l

—

Other diseases of blood and blood-forming organs

179

1.23

0.37

1.0

1.1

10.09

4.30

nmol/l

—

Ankylosing hyperostosis [Forestier]

1.35

0.37

1.0

1.1

—

6.12

—

LSIL lesion of the cervix uteri, vagina or vulva

421

1.14

0.36

1.0

1.1

0.30

4.15

nmol/l

1.22

Viral pneumonia

318

1.16

0.36

1.1

2.26

9.96

nmol/l

—

Unspecified lump in breast

440

1.14

0.36

1.1

6.47

11.80

nmol/l

—

Colectomy operation

412

1.14

0.36

1.1

32.17

8.85

nmol/l

0.43

Malignant neoplasm of breast

123

858

0.92

0.36

1.1

1.85

6.34

nmol/l

1.75

148

Mental and behavioural disorders due to alcohol, excluding acute intoxication

138

1271

1.08

0.36

1.1

0.63

7.07

nmol/l

3.83

231

Hypoplasia of dental enamel , including avohilmo

0.64

0.35

1.0

1.1

—

0.19

—

Other, unspecified and serous retinal detachments

0.63

0.35

1.0

1.1

—

3.18

—

Benign neoplasm: Conjunctiva

1.32

0.35

1.0

1.1

—

1.79

—

Other chronic obstructive pulmonary disease

122

923

1.08

0.35

1.0

1.1

7.12

7.31

nmol/l

0.02

179

Other benign neoplasms of connective and other soft tissue

254

1.18

0.35

1.1

4.71

5.63

nmol/l

—

Biological medication for rheuma

498

1.13

0.35

1.1

8.42

4.64

nmol/l

—

Malignant neoplasm of breast, HER2-negative

123

857

0.92

0.35

1.1

1.85

6.34

nmol/l

1.75

148

Other endocrine disorders

119

0.72

0.35

1.1

1.2

—

1.87

nmol/l

—

Pregnancy with abortive outcome

230

1131

1.06

0.35

1.1

1.52

7.50

nmol/l

1.96

194

malignant neoplasm of female genital organs

407

0.86

0.35

1.0

32.58

8.67

nmol/l

—

Heart failure, strict

179

1167

1.07

0.34

1.1

7.53

7.13

nmol/l

0.04

226

Granulomatous disorders of skin and subcutaneous tissue

1.37

0.34

1.0

1.1

4.11

2.27

nmol/l

—

Other disorders of breast and lactation associated with childbirth

1.37

0.34

1.0

—

10.25

—

Malignant neoplasm of ovary, including Hilmo

163

1.23

0.34

1.1

1.0

65.07

11.77

nmol/l

—

Chronic kidney disease

774

1.09

0.34

1.1

2.04

10.12

nmol/l

2.60

149

Seropositive rheumatoid arthritis, wide

729

1.10

0.33

1.1

2.95

8.52

nmol/l

1.01

144

Pedal cyclist injured in collision with motor vehicle

0.70

0.33

1.0

1.1

—

1.56

—

Simple and mucopurulent chronic bronchitis

0.70

0.33

1.0

1.1

—

3.83

—

Other sexually transmitted chlamydial diseases, including avohilmo

253

0.83

0.33

1.1

1.73

4.04

nmol/l

—

Malignant neoplasm of skin

166

1054

1.07

0.33

1.1

3.21

6.82

nmol/l

1.51

192

Hereditary corneal dystrophies

1.31

0.32

1.2

6.78

2.72

nmol/l

—

Contusion of ankle

110

1.27

0.31

1.0

1.1

0.15

4.01

nmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

334

1897

1.04

0.31

1.1

4.27

5.75

nmol/l

0.39

346

Atherosclerosis, excluding cerebral and coronary sclerosis

841

0.92

0.31

1.1

1.88

8.93

nmol/l

2.56

180

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

211

1.19

0.31

1.2

1.1

20.97

5.10

nmol/l

—

Short Achilles tendon (acquired)

1.35

0.31

1.0

1.1

—

2.32

nmol/l

—

HSIL lesion of the cervix uteri

559

0.89

0.31

1.0

1.1

0.08

2.25

nmol/l

—

Malignant neoplasm of corpus uteri

197

0.81

0.31

1.0

0.09

9.55

nmol/l

—

Assault

343

1.14

0.30

1.1

2.03

5.18

nmol/l

—

Diabetic nephropathy, excluding more controls

274

0.86

0.30

1.1

0.86

6.63

nmol/l

—

Any dementia

110

706

1.08

0.30

1.0

1.1

1.54

9.93

nmol/l

2.62

146

Malignant neoplasm of ovary

120

1.25

0.30

1.1

1.0

65.07

13.90

nmol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

175

1.20

0.30

1.1

0.12

3.80

nmol/l

—

Open wound of ankle and foot

269

1.15

0.29

1.0

1.1

2.75

4.59

nmol/l

—

Fracture of forearm

183

1557

1.06

0.29

1.1

12.58

5.82

nmol/l

0.28

292

Antenatal screening

346

1.10

0.29

1.0

1.1

0.09

4.21

nmol/l

—

Cellulitis

602

1.10

0.28

1.0

1.1

1.82

10.67

nmol/l

2.12

122

Mucosal proctocolitis

326

1.14

0.28

1.1

0.09

5.54

nmol/l

—

ILD, hospital admissions 1, main diag only

333

0.87

0.27

1.0

1.1

5.18

13.64

nmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

459

0.90

0.27

1.2

1.0

11.64

8.10

nmol/l

0.28

Asthma and opportunity respiratory infection

113

1.24

0.26

1.1

13.92

10.39

nmol/l

—

Non-ischemic cardiomyopathy

661

0.92

0.26

1.1

5.97

8.59

nmol/l

0.28

131

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.27

0.26

1.0

1.1

0.71

3.33

nmol/l

—

Postprocedural disorders of digestive system, not elsewhere classified

1.27

0.26

1.0

1.1

—

4.31

—

Colorectal cancer, including Hilmo

669

0.92

0.26

1.1

5.89

6.85

nmol/l

0.09

131

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

522

0.91

0.25

1.2

1.0

10.81

7.06

nmol/l

0.34

107

Tumor necrosis factor alpha inhibitors

453

1.10

0.25

1.1

9.17

4.43

nmol/l

—

Lymphoid leukaemia

127

0.79

0.25

1.1

1.2

—

4.34

—

Benign neoplasm: Transverse colon

282

1.14

0.25

1.1

3.93

14.22

nmol/l

—

COPD, hospital admission 2, with asthma infections

730

1.07

0.25

1.0

1.1

5.75

8.28

nmol/l

0.25

147

Other chronic obstructive pulmonary disease, including avohilmo

162

1263

1.05

0.25

1.0

1.1

5.56

7.57

nmol/l

0.30

247

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

484

1.10

0.24

1.1

0.90

6.23

nmol/l

—

Diabetic retinopathy, strict definition

353

1.11

0.23

1.0

1.1

0.09

5.88

nmol/l

—

Delirium, not induced by alcohol and other psychoactive substances

283

1.13

0.23

1.0

1.1

0.09

8.50

nmol/l

—

Persistent delusional disorders

199

1.16

0.23

1.1

4.37

4.90

nmol/l

—

Hypothyroidism due to medicaments and other exogenous substances

1.32

0.23

1.0

1.1

—

0.15

—

Malignant neoplasm of vulva, including Hilmo

1.32

0.23

1.0

—

8.02

—

Malignant neoplasm of breast, including Hilmo

128

866

0.95

0.23

1.1

1.73

6.30

nmol/l

1.86

149

Malignant neoplasm of breast, HER2-negative, including Hilmo

128

866

0.95

0.23

1.1

1.73

6.30

nmol/l

1.86

149

Benign neoplasm: Vagina

1.28

0.23

1.0

1.1

—

1.39

—

Carcinoma in situ of rectum

1.28

0.23

1.2

1.1

—

0.13

—

Embedded and impacted teeth

597

1.07

0.23

1.2

1.1

1.30

3.76

nmol/l

0.77

101

Residual foreign body in soft tissue

1.24

0.23

1.0

1.1

—

5.01

—

HSIL lesion of the cervix uteri, vagina or vulva

619

0.92

0.23

1.1

0.08

3.92

nmol/l

—

106

Other disorders of kidney and ureter

323

1.12

0.22

1.1

8.33

8.15

nmol/l

—

Marginal zone B-cell lymphoma, including Hilmo

1.25

0.22

1.0

1.1

—

5.03

—

Diabetes, insulin treatment (Kela reimbursement)

355

2046

1.03

0.22

1.1

4.29

5.88

nmol/l

0.45

368

Any death

191

1393

0.96

0.22

1.1

13.44

6.26

nmol/l

0.42

260

Atrophic disorders of skin

458

1.09

0.22

1.0

1.1

10.69

10.52

nmol/l

—

Endovascular or surgical operations to intracerebral aneurysms

144

1.18

0.22

1.1

8.93

10.70

nmol/l

—

Streptococcal septicaemia

210

1.14

0.21

1.1

5.85

10.15

nmol/l

—

Lichenoid drug reaction

0.00

0.21

0.0

1.2

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.0

—

Other acute viral hepatitis

1.19

0.21

1.2

1.1

—

0.08

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.21

0.0

1.0

—

Monocytic leukaemia

0.00

0.21

0.0

1.2

—

Benign neoplasm: Floor of mouth

0.00

0.21

0.0

1.2

—

Benign neoplasm: Hypopharynx

0.00

0.21

0.0

1.2

—

Malignant neoplasm

301

1704

1.03

0.21

1.1

10.67

5.21

nmol/l

0.42

304

Medical treatment for female infertility

662

0.93

0.21

1.1

0.84

3.09

nmol/l

0.77

Glomerular diseases

461

0.91

0.21

1.1

1.98

11.89

nmol/l

—

Yaws, including avohilmo

0.00

0.21

0.0

1.2

—

Benign neoplasm of urinary organs

126

1.19

0.21

1.1

0.43

3.52

nmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.24

0.21

1.3

1.1

—

4.48

—

Unspecific neurodegenerative disorder

105

760

0.95

0.20

1.0

1.1

5.08

10.00

nmol/l

0.74

160

Conductive hearing loss, unspecified

211

1.14

0.20

1.0

1.1

7.33

5.14

nmol/l

—

Malignant neoplasm of breast, HER-negative

531

0.92

0.20

1.1

1.0

3.30

7.00

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

593

1.07

0.20

1.0

1.1

9.35

9.67

nmol/l

0.02

118

N06DA Anticholinesterases

676

1.06

0.20

1.0

1.1

8.03

9.10

nmol/l

0.08

145

Use of anticholinesterases

676

1.06

0.20

1.0

1.1

8.03

9.10

nmol/l

0.08

145

Nonischemic cardiomyopathy

250

0.88

0.20

1.1

1.20

7.98

nmol/l

—

Other and unspecified vascular occlusions

218

0.87

0.19

1.1

2.65

16.69

nmol/l

—

Premature rupture of membranes

445

1.07

0.19

1.0

1.1

2.97

3.77

nmol/l

—

Benign neoplasm: Descending colon

184

1.14

0.19

1.0

1.1

0.20

6.55

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis

724

1.06

0.19

1.1

2.95

8.68

nmol/l

1.04

141

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.13

0.18

1.0

1.1

—

1.15

—

Single delivery by caesarean section

291

0.92

0.18

1.1

3.97

5.26

nmol/l

—

Benign neoplasm: Kidney

100

1.20

0.18

1.2

1.1

0.43

4.24

nmol/l

—

Congenital malformations of genital organs

250

1.11

0.18

1.1

0.11

4.60

nmol/l

—

Iridocyclitis in diseases classified elsewhere

1.19

0.18

1.1

—

1.38

—

Other appendicitis

223

1.12

0.18

1.0

1.1

2.50

3.57

nmol/l

—

Nontraumatic intracranial haemmorrhage

435

0.92

0.18

1.1

5.19

12.58

nmol/l

—

Other complications of labour and delivery, not elsewhere classified

317

1.09

0.17

1.1

3.17

5.27

nmol/l

—

Retinal vascular disorders

289

0.90

0.17

1.1

2.25

14.11

nmol/l

—

Maternal care for known or suspected disproportion

110

1.18

0.17

1.0

1.1

—

6.53

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.22

0.17

1.1

—

4.14

—

Mumps, including avohilmo

0.76

0.17

1.0

1.1

—

1.22

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

718

1.06

0.17

1.1

2.95

8.68

nmol/l

1.04

141

Malignant neoplasm

299

1703

1.03

0.16

1.1

10.87

5.23

nmol/l

0.43

303

Pedal cyclist injured in transport accident

629

0.94

0.16

1.1

3.58

9.13

nmol/l

0.70

115

Other and unspecified nail disorders

1.16

0.16

1.0

1.1

—

1.68

—

Chronic mastoiditis

1.16

0.16

1.1

—

3.09

—

Aortic aneurysm

571

1.06

0.16

1.0

1.1

3.29

8.72

nmol/l

1.34

121

Malignant neoplasm of skin, including Hilmo

172

1111

1.04

0.16

1.1

3.54

6.62

nmol/l

1.22

203

Other benign neoplasms of uterus

130

0.85

0.16

1.0

1.1

—

9.67

—

Malignant neoplasm of rectum, including Hilmo

297

0.91

0.15

1.0

1.1

0.89

10.17

nmol/l

—

Respiratory tuberculosis, not confirmed

0.75

0.15

1.0

1.2

—

4.50

—

Respiratory tuberculosis, not confirmed, including avohilmo

0.75

0.15

1.0

1.2

—

4.50

—

Nephropathy related operations

286

0.91

0.15

1.1

1.14

8.55

nmol/l

—

Oesophageal obstruction

1.08

0.14

1.2

1.1

—

4.33

—

Other maltreatment syndromes

0.79

0.14

1.0

1.1

—

0.40

—

Peripheral artery disease

119

903

1.04

0.14

1.1

1.53

8.64

nmol/l

2.93

190

Glomerular disorders in diseases classified elsewhere

275

0.91

0.14

1.0

1.1

1.13

8.59

nmol/l

—

Other disorders of amniotic fluid and membranes

350

1.08

0.14

1.1

0.12

2.51

nmol/l

—

Injury of eye and orbit

353

1.08

0.14

1.1

1.15

8.15

nmol/l

—

Acute alcohol intoxication ICD-9

1.19

0.14

1.1

—

5.26

—

Amiodarone users

237

1.10

0.14

1.0

1.1

6.30

10.10

nmol/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

103

1.17

0.13

1.2

1.1

1.00

2.14

nmol/l

—

Pleural effusion

363

1.07

0.13

1.1

2.50

13.15

nmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

907

1.04

0.13

1.1

0.23

7.36

nmol/l

2.03

147

Other malignant neoplasms of skin (=non-melanoma skin cancer)

144

944

1.03

0.13

1.1

1.0

3.07

6.50

nmol/l

1.17

176

Other ulcerative colitis

149

0.87

0.13

1.0

1.1

—

4.34

—

Retinal vascular occlusion

284

0.92

0.13

1.1

2.25

14.14

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

407

0.93

0.13

1.0

1.1

5.11

8.22

nmol/l

—

Primary angle-closure glaucoma

108

0.83

0.13

1.0

1.1

—

11.18

—

Streptococcal septicaemia, including avohilmo

219

1.10

0.12

1.1

5.85

9.73

nmol/l

—

Melanoma in situ

123

1.14

0.12

1.0

1.1

3.86

7.81

nmol/l

—

Normotensive glaucoma

210

1.10

0.12

1.3

1.1

1.17

16.25

nmol/l

—

Alcohol-induced chronic pancreatitis

162

1.11

0.11

1.1

5.56

5.27

nmol/l

—

Other embolism and thrombosis

327

1.07

0.11

1.0

1.1

0.52

9.37

nmol/l

—

malignant neoplasm of female genital organs, including Hilmo

451

1.06

0.11

1.1

1.0

29.62

8.24

nmol/l

0.31

Fibrosis and cirrhosis of liver

201

1.10

0.11

1.1

19.54

7.48

nmol/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

578

0.95

0.11

1.1

1.0

2.84

6.96

nmol/l

—

100

Obstructed labour due to malposition and malpresentation of fetus

647

0.96

0.10

1.1

0.16

5.21

nmol/l

—

Glomerulonephritis

239

0.92

0.10

1.2

1.1

2.64

5.19

nmol/l

—

Alcohol dependence

698

0.96

0.10

1.1

0.65

6.68

nmol/l

4.90

133

Erectile dysfunction

154

1.10

0.10

1.1

7.10

9.14

nmol/l

—

COPD-related respiratory insufficiency

271

1.07

0.09

1.0

1.1

1.42

10.59

nmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

1.06

0.09

1.0

1.1

—

2.51

—

Respiratory conditions due to other external agents

1.06

0.09

1.0

1.1

—

1.20

—

Other disorders involving the immune mechanism, not elsewhere classified

1.15

0.09

1.1

—

3.78

—

Single spontaneous delivery

121

621

1.03

0.09

1.1

12.09

4.72

nmol/l

0.57

120

Malignant neoplasm of urinary organs, including Hilmo

272

1.07

0.09

1.1

1.0

0.20

9.43

nmol/l

—

Inguinal hernia, bilateral

237

0.93

0.09

1.1

0.77

8.87

nmol/l

—

Communicating hydrocephalus

1.09

0.09

1.3

1.1

—

1.27

—

Tooth eruption problems

348

1.05

0.08

1.1

0.09

3.82

nmol/l

—

Use of antiglaucoma preparations and miotics

175

0.91

0.08

1.0

1.1

2.50

9.49

nmol/l

—

Wet age-related macular degeneration

376

1.05

0.08

1.1

0.94

13.88

nmol/l

—

Disorders of optic nerve, not elsewhere classified

1.03

0.08

1.0

1.1

—

2.02

—

Viral agents as the cause of diseases classified to other chapters

0.82

0.08

1.0

1.1

—

0.30

—

Hypertrichosis

0.83

0.08

1.0

1.1

—

7.01

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

0.81

0.08

1.0

1.1

—

3.43

—

Mumps

0.79

0.08

1.0

1.1

—

1.22

—

Contact with sharp object, undetermined intent

1.09

0.08

1.3

1.1

—

1.65

—

Thiazolidinediones

283

1.06

0.08

1.0

1.1

5.45

13.50

nmol/l

—

Inguinal or femoral hernia, bilateral

246

0.93

0.08

1.1

0.77

8.46

nmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

167

1283

1.02

0.08

1.0

1.1

8.32

6.68

nmol/l

0.17

248

Complications of labour and delivery

209

1140

1.02

0.07

1.1

1.98

7.52

nmol/l

1.38

193

Benign neoplasm of major salivary glands

256

0.94

0.07

1.0

1.1

0.22

8.83

nmol/l

—

Disorders of globe

0.84

0.07

1.2

1.1

—

2.76

—

Postpartum hemorraghe, all women as controls

767

1.03

0.07

1.1

0.18

3.85

nmol/l

1.59

122

Right hemicolectomy

143

0.91

0.07

1.1

78.63

3.47

nmol/l

—

Other benign neoplasms of skin

112

1094

1.02

0.07

1.0

1.1

3.00

7.61

nmol/l

1.37

208

Pedal cyclist injured in other and unspecified transport accidents

296

0.95

0.07

1.1

5.76

7.14

nmol/l

—

Ulcerative enterocolitis

0.85

0.07

1.0

1.1

—

0.32

—

Paralytic ileus

1.05

0.07

1.1

—

4.68

—

Assault by bodily force

206

1.07

0.07

1.2

1.1

0.13

3.07

nmol/l

—

Other secondary coxarthrosis

1.12

0.07

1.0

1.1

13.63

0.79

nmol/l

—

Caught, crushed, jammed or pinched in or between objects

142

0.92

0.06

1.1

6.94

2.22

nmol/l

—

All dysplastic lesions of the cervix uteri

817

1.02

0.05

1.0

1.1

0.26

4.05

nmol/l

1.99

129

Benign mammary dysplasia

375

1.04

0.05

1.1

0.55

13.34

nmol/l

—

Coronary artery bypass grafting

443

0.97

0.05

1.0

1.1

0.11

11.10

nmol/l

—

105

COPD, early/later onset

122

1042

0.98

0.05

1.0

1.1

7.12

7.28

nmol/l

0.01

209

Other and unspecified injuries of wrist and hand

100

1.10

0.05

1.2

1.1

—

1.31

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

147

976

1.02

0.05

1.1

3.41

6.79

nmol/l

1.14

181

Follicular cysts of skin and subcutaneous tissue

485

1.03

0.05

1.1

0.62

11.10

nmol/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

383

0.97

0.04

1.1

1.00

6.86

nmol/l

—

Multiple delivery

209

1.05

0.04

1.1

0.12

5.96

nmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

231

0.95

0.04

1.0

1.1

0.24

9.18

nmol/l

—

Benign neoplasm of ovary

467

1.03

0.04

1.1

13.82

8.81

nmol/l

0.23

Benign neoplasm: Skin of other and unspecified parts of face

269

1.04

0.04

1.0

1.1

3.04

9.35

nmol/l

—

Abnormalities of forces of labour

281

0.96

0.04

1.1

0.10

7.41

nmol/l

—

COPD, hospital admissions

121

1033

0.99

0.03

1.0

1.1

7.12

7.29

nmol/l

0.02

207

Status post-ami

465

0.98

0.03

1.0

1.1

0.11

11.31

nmol/l

—

103

In situ neoplasms

120

1185

1.01

0.03

1.1

6.20

6.95

nmol/l

0.09

224

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

449

1.02

0.03

1.1

1.00

5.96

nmol/l

—

COPD related to multimorbidity

106

884

1.01

0.03

1.0

1.1

7.87

8.20

nmol/l

0.03

176

Toxic effect of contact with venomous animals

118

0.93

0.02

1.1

0.30

1.44

nmol/l

—

Dialysis, with operation codes

299

0.97

0.02

1.1

1.14

9.01

nmol/l

—

Solid cancers

285

1679

0.99

0.02

1.1

10.86

5.35

nmol/l

0.41

296

Ulcerative colitis (strict definition, require KELA)

461

1.02

0.02

1.1

1.00

5.86

nmol/l

—

Impacted teeth

471

0.98

0.02

1.2

1.1

1.83

4.30

nmol/l

—

Arthropathic psoriasis

302

1.03

0.02

1.1

20.03

5.09

nmol/l

—

Otitis externa, unspecified

322

1.02

0.01

1.2

1.1

9.38

5.54

nmol/l

—

Laparoscopic right hemicolectomy

153

1.05

0.01

1.0

1.1

17.59

9.75

nmol/l

—

Delivery

119

623

1.01

0.00

1.1

11.49

4.72

nmol/l

0.55

120

Purpura and other haemorrhagic conditions

336

0.98

0.00

1.0

1.1

2.67

10.75

nmol/l

—

Postpartum haemorrhage

669

1.00

0.00

1.1

0.18

4.34

nmol/l

1.61

108

Personal history of malignant neoplasm

218

1.01

0.00

1.2

1.1

1.14

14.22

nmol/l

—

Malignant neoplasm of urinary organs

235

1.02

0.00

1.0

1.1

0.20

10.60

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

245

1.02

0.00

1.1

0.20

10.25

nmol/l

—

Malignant neoplasm of colon, including Hilmo

465

1.01

0.00

1.1

1.0

6.90

8.03

nmol/l

0.09

Transplanted organ and tissue status

226

1.02

0.00

1.1

2.30

5.76

nmol/l

—

Spontaneous abortion

150

1001

1.00

0.00

1.1

0.83

8.12

nmol/l

2.41

167

Maternal care for other known or suspected fetal problems

435

0.99

0.00

1.1

4.77

3.87

nmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

297

1.01

0.00

1.1

0.23

4.48

nmol/l

—

Benign neoplasm: Parotid gland

208

1.01

0.00

1.0

1.1

0.27

6.81

nmol/l

—

Complications following abortion and ectopic and molar pregnancy

1.01

0.00

1.0

1.1

—

7.32

—

Malignant neoplasm of colon

376

1.01

0.00

1.2

1.0

8.13

8.77

nmol/l

0.04

Unspecified kidney failure

249

1.00

0.00

1.0

1.1

3.27

11.27

nmol/l

—

Lichen sclerosus et atrophicus

319

1.00

0.00

1.0

1.1

10.85

13.01

nmol/l

—

Postpartum hemorraghe, parous women as controls

678

1.00

0.00

1.1

0.18

2.70

nmol/l

1.34

105

Alcohol use disorder, ICD-based

120

1203

1.00

0.00

1.1

0.65

7.17

nmol/l

3.66

222

Degenerative diseases of the nervous system

679

1.01

0.00

1.0

1.1

1.30

9.58

nmol/l

2.49

147

Subarachnoid haemorrhage

229

1.00

0.00

1.1

0.75

18.17

nmol/l

—

Personal history of other diseases and conditions

293

1.02

0.00

1.1

4.67

4.02

nmol/l

0.07

Cyst of kidney

183

0.98

0.00

1.1

14.93

9.96

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis

217

1.01

0.00

1.0

1.1

0.20

10.99

nmol/l

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.4

—

Iodine-deficiency-related goitre

0.00

0.0

1.3

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.0

—

Radiodermatitis

0.00

0.0

1.3

—

Thoracic root disorders

0.00

0.0

1.0

—

Calcium deposit in bursa

0.00

0.0

1.0

—

Overjet

0.99

0.00

1.0

1.2

—

0.22

—

Dysplastic lesion of the vulva of unknown severity

0.00

0.0

1.0

—

Erysipeloid, including avohilmo

0.00

0.0

1.0

—

Hirsutism in women

0.94

0.00

1.0

1.1

—

7.87

—

Sunburn

0.00

0.0

1.3

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.0

1.0

—

Primary Sclerosing Cholangitis, IBD and UDCA required

1.00

-0.00

1.0

1.1

—

1.15

—

Blindness or visual impairment, binocular

0.00

-0.00

0.0

1.0

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

-0.00

0.0

1.3

—

Rapidly progressive nephritic syndrome

0.00

-0.00

0.0

1.4

—

Enterobiasis, including avohilmo

0.86

-0.00

1.0

1.1

—

4.78

—

Flexion deformity

0.00

-0.00

0.0

1.0

—

Other disorders of Eustachian tube

1.01

-0.00

1.0

1.1

—

2.86

nmol/l

—

Exposure to smoke, fire and flames

0.95

-0.00

1.2

1.1

—

0.86

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Rickettsioses, including avohilmo

0.00

-0.00

0.0

1.3

—

Exposure to controlled fire, not in building or structure

0.00

-0.00

0.0

1.4

—

Cutaneous autosensitization

0.00

-0.00

0.0

1.0

—

Intermittent hydrarthrosis

0.00

-0.00

0.0

1.0

—

Hookworm diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Other helminthiases

0.00

-0.00

0.0

1.0

—

Diffuse (eosinophilic) fasciitis

0.00

-0.00

0.0

1.0

—

Lordosis

0.00

-0.00

0.0

1.4

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

Disorders of sexual preference

0.00

-0.00

0.0

1.4

—

Severe mental retardation

0.00

-0.00

0.0

1.8

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.3

—

Hypotony of eye

0.00

-0.00

0.0

1.3

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.0

—

Endocrine disorders, other/unspecified

0.88

-0.00

1.0

1.1

—

1.20

nmol/l

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.3

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

1.3

—

Polyp of middle ear

0.00

-0.00

0.0

1.3

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

1.0

—

Hereditary sideroblastic anaemia

0.00

-0.00

0.0

1.3

—

Upper arm

0.00

-0.00

0.0

1.3

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.3

—

Choroidal detachment

0.00

-0.00

0.0

1.3

—

Choroidal degeneration

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

-0.00

0.0

1.0

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.3

—

Crushing injury of forearm

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.3

—

Traumatic secondary and recurrent haemorrhage

0.00

-0.00

0.0

1.4

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

1.0

—

Other retinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

Rickettsioses

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

-0.00

0.0

1.2

—

Kyphoscoliotic heart disease

0.00

-0.00

0.0

1.0

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.2

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

1.0

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.0

—

Hereditary lymphedema

0.00

-0.00

0.0

1.3

—

Burns and corrosions of multiple and unspecified body regions

0.94

-0.00

1.2

—

0.87

—

Abscess of mediastinum

0.00

-0.00

0.0

1.0

—

Postpolio syndrome

0.00

-0.00

0.0

1.3

—

Secondary sideroblastic anaemia

0.00

-0.00

0.0

1.0

—

Congenital malposition of the kidney

0.00

-0.00

0.0

1.3

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Other infective spondylopathies

0.00

-0.00

0.0

1.3

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.4

—

Human immunodeficiency virus [HIV] disease

0.91

-0.00

1.0

1.1

—

0.11

nmol/l

—

Hereditary lymphedema, including avohilmo

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.6

—

Myelodysplastic syndrome, including Hilmo

1.02

-0.00

1.0

1.1

—

9.06

—

Kaposi sarcoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Chondrosarcoma

0.00

-0.00

0.0

1.0

—

Ependymoma

0.00

-0.00

0.0

1.0

—

Other congenital malformations of integument, including avohilmo

0.00

-0.00

0.0

1.3

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.2

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.5

—

Human immunodeficiency virus [HIV] disease, including avohilmo

0.86

-0.00

1.0

1.1

—

1.17

nmol/l

—

ILD medications: nintedanib

0.00

-0.00

0.0

1.4

—

conjunctival scars

0.00

-0.00

0.0

1.0

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acetylcholine receptor Ab [Moles/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS